Page 1

Vol.8 No.6 | November-December 2016 | New Delhi

SHOW|REPORT

MEDICA & COMPAMED

NEW PRODUCTS LAUNCHED

Apollo Hospitals - a SuperSpeciality Hospital

SOLED15 - LED light for universal applications Medical Device ASIA | November-December 2016 | 1


e

d

i

t

o

r

i

a

l

h i g h l i g h t s

Vol.8 No.6 | November-December 2016 | Annual Suscription: Rs.2,000 | Overseas: US$250

4 SOLED15 - LED light for universal applications 6 UK Cervical Cancer Diagnostic System 8 Virtual Reality vision for robotic rehabilitation 12 Apollo Hospitals - a World-class Hospital in Navi Mumbai 16 Cross learning from best practices on Family Planning 18 MEDICAL FAIR THAILAND 2017 20 MTA2017 to spotlight new technologies with specialised zones 22 HKTDC International Medical Devices and Supplies Fair 26 OSH India 2016 - Occupational Safety and Health industry event 30 Clean Air For Everyone 31 MEDICA and COMPAMED 2016 - Show Report 37 New large steam sterilisers 38 The new Medical Device Regulation 41 Medical workflow innovations at MEDICA 2016 42 World Diabetes Day 45 Beurer AS 95: Keeping up with day-to-day life 46 Unique handheld ultrasound device 48 CuratOR Surgical Panels 54 India Medical Show 2017

New Merivaara Q-Flow surgical light can reduce the risk of hospital infections Merivaara Q-FlowTM surgical light improves the working environment in operating rooms as well as offers a new way to reduce the risk of infections.

innovations.

The new Merivaara Q-Flow is a major step forward from traditional operating room lights. Designed and manufactured in Finland, Q-Flow was developed to fulfil the needs of the modern surgical team. It offers improvements on many standard features in the industry as well as radical

“I believe this is one of the very best operating theatre lights in the whole world,” says CEO Markku Aherto. “We are very excited about this excellent product.” The light gives superb colour rendering, particularly in red and skin shades, which make the product perfect for a variety of surgeries such as internal or plastic surgery. The Q-Flow gives a very deep column of light and dynamic obstacle compensation, so if the surgeon bends over her patient sensors brighten other LEDs to reduce shadows. Moreover, the light has sterile intuitive controls. The Q-Flow displays simple user

instructions onto the operating table so the surgeon does not have to look up. “We had surgeons, anaesthesiologists and nurses give us their input as we developed the Q-Flow,” Aherto continues. “They are very positive about the final result.” One of the most ground-breaking features is the way it improves hygienic conditions. Standard operating room lights create turbulence intensity, acting like an aircraft wing to pull particulates in the air right over the patient. Merivaara’s designers shaped the Q-Flow as a series of concentric circles with open spaces in between. This improves laminar air flow so sterile conditions are maintained and the risk of infection is reduced. The standard turbulence intensity should be below 37.5% but the Q-Flow boasts 15.9% according to the DIN 19464:2008 standard.

The Q-Flow is a part of the Merivaara FluentTM concept, which enhances the usability of operating rooms. This includes an intuitive user interface which works across a variety of devices, such as Q-Flow, operating tables and an integrated operating system. Often a single operating room may have equipment with different user interfaces. With Merivaara Fluent, each device can have the same user interface, allowing the medical staff to concentrate on the patient instead of learning how to use the devices. “All the Q-Flow’s design and technology is Finnish,” concludes Aherto. “Finnish health tech has such a good reputation around the globe. I am proud that we can offer something to the world which contributes to Finland’s great reputation.”

Medical Device ASIA | November-December 2016 | 3


WORLDWIDE MEDICAL EQUIPMENT

SOLED15 - LED light for universal applications SOLED15 is the LED examination light for surgery and universal applications. It can care, recovery room, first aid, cosmetic sector.

diagnostics, minor be used for intensive surgery and dental

SOLED15 contains all the advantages of LED is suitable for multi-purpose uses thanks to its It assures: • excellent light intensity • IR-free light beam • colour temperature (CCT) of 4.500°K • colour rendering index (CRI) of 95 • long life • low power consumption

technology and flexibility.

The new “SEL” function allows the selection of single parts of the light beam and the activation of the desired LEDs in a sequential way according to the requirements and needs. “Boost” function or “brightness increase” is used to obtain a maximum light intensity in case of a wide light field. This approximate 20% increase deactivates automatically after 5 minutes.

The high technological level combined with high-powered LEDs allow SOLED15 to have a and a negligible performance decay for its entire life

the use of very linear yield duration.

Thanks to the high efficiency achieved, SOLED15 has of 65.000 Lux (85.000 Lux with “Boost” function) power consumption (16W).

a light intensity and a low

The LEDs layout gives a visual comfort and produces homogeneous and shadowless light.

a uniform,

SOLED15 has a round shape that makes it handy and both in use and move.

functional

Its easy-to-move structure is suitable for diagnostics, dental surgery and its easy-to-grip removable and handle makes it suitable even for critical sanitary

test labs and sterilizable applications.

SOLED15 is provided with an I-Sense touch panel

to control all

4 | November-December 2016 | Medical Device ASIA

the functions of the lamp: • ON/OFF • Light intensity adjustment • Parts selection (SEL) • Brightness increase (Boost)

SOLED15 is available in the following versions Ceiling mounted, Wall mounted, Trolley mounted (ABPS battery on demand). SOLED15, with ABPS battery, has the same performance and appearance, since the structure containing the battery is within the trolley base. The structure which covers and protects the battery is made of resistant plastic, and its dimensions are: 550 x 340 x 240. The control panel on the structure allows managing all fundamental parameters, such as residual charge, type of power supply, recharge status and electrical power supply presence, amongst others. ABPS is a rechargeable battery powered system made by ACEM Medical Company dedicated to power surgical lamps as by European Directive 93/42/EEC. For further information: ACEM SPA, Medical Company Division Tel +39 – 051 – 721844 Fax +39 – 051 - 721855 info@acem.it www.acem.it


M

Y

Y

Y


UK cervical cancer diagnostic system to be piloted in India as part of TechEmerge’s programme

Zilico Ltd – a developer of a pioneering cervical cancer diagnostic system - has been selected by the IFC, a member of the World Bank Group, to be part of a unique program across India.

disease (HGCIN) across all patients, with 50% increase reported in women with low-grade cytology. In 92% of these cases, disease was confirmed with a single biopsy.

TechEmerge is the first programme of its kind that brings together proven technology companies such as Zilico, with leading healthcare providers in emerging markets.

It is estimated there are approximately 132,000 new cases diagnosed and 74,000 deaths annually in India, which accounts for nearly a third of the global cervical cancer deaths.

Chosen from 330 innovators across 29 countries, the inaugural program will see the company working with International Oncology Services, with the aim of increasing the early detection of cervical cancer across India and quickly enabling treatment.

Although colposcopy is an important method in detecting cervical cancer, in practice, the procedure has not drastically changed over the last 90 years, and diagnosis depends on the subjective assessment of visual indicators by the clinician.

ZedScan™ uses the science of Electrical Impedance Spectroscopy (EIS) to detect the development of pre-cancerous abnormalities of the cervix.

Using ZedScan as an adjunct to the existing colposcopy procedure will help clinicians better manage patients and help avoid unnecessary biopsies, treatments and repeat follow-up appointments.

The portable, handheld device is already being used in hospitals across the UK and other countries, provides a more accurate diagnosis in real-time, which assists clinicians with better patient management. In a recent review of over 1500 women referred to an UK colposcopy clinic, the adoption of ZedScan resulted in a significant increase in disease detection and improvements in clinical performance. The patient case study revealed a 13% increase in detection of high-grade 6 | November-December 2016 | Medical Device ASIA

Cervical cancer, which is caused by Human Papillomavirus infection, is the leading cancer in Indian women. It is the second most common cancer in women worldwide.

Colposcopy referrals are also expected to increase dramatically following the introduction of HPV screening and ZedScan can provide a costeffective means to accommodate this growth. Sameer Kothari, Chief Executive of Zilico Ltd, said: “We are delighted that Zilico has been chosen as one of TechEmerge’s successful matches and look forward to working with International Oncology Services to implement ZedScan and help improve healthcare delivery in India.” v


Dates announced for MEDICAL FAIR THAILAND 2017 The 8th edition of MEDICAL FAIR THAILAND, the leading medical and healthcare event in Thailand and the region, will take place at the Queen Sirikit National Convention Centre (QSNCC) in Bangkok, Thailand from 6 – 8 September 2017.

S

ince its inception in 2003, MEDICAL FAIR THAILAND has grown in size, stature and is recognised as Thailand’s most important resource and business platform for both international and regional suppliers from the medical and healthcare sectors. In 2015, MEDICAL FAIR THAILAND held its largest edition to date as it welcomed 600 exhibitors from 42 countries including 15 national pavilions and country groups from Austria, Belgium, China, France, Germany, Japan, Malaysia, Singapore, South Korea, Taiwan, Thailand, UK and for the first time the USA, Turkey and Italy. The testament to the exhibition’s success was further reflected in the number of visitors, as the 7th edition welcomed 7,226 quality trade

buyers and decision makers from mainly Thailand and the ASEAN region. Focused on equipment and supplies for the hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors, MEDICAL FAIR THAILAND 2017 will once again bring together new and innovative technologies, solutions, products and services from around the world. In its upcoming edition, the exhibition will emphasise on Connected Healthcare and Geriatric Rehabilitative Care across two dedicated platforms and numerous concurrently held events. For one, the Connected Healthcare platform aims to demonstrate innovative digital solutions such as wearables that are transforming the understanding of patient’s health statuses, improve care and deliver greater results. At the same time, and returning for its 3rd edition, the Advanced

Rehab Technology Conference (ARTeC) will focus on innovative and effective technological solutions to decrease mobility related disabilities. Co-organised by the Thai Rehabilitation Medicine Association, the Royal College of Physiatrists of Thailand and Messe Düsseldorf Asia, the academic conference will welcome international key thought leaders to share insights on robotic transfer systems, robotic arm training devices, robotic gait training and wearable devices. Serving as a converging point for healthcare providers, medical suppliers, industry professionals, government bodies, hospital administrators, doctors, nurses and other healthcare professionals sourcing for the latest innovations in medical and healthcare, MEDICAL FAIR THAILAND 2017 is expected to draw 700 exhibitors, 17 national pavilions and country groups and 8,500 quality trade visitors. Bookings for exhibitor spaces are now open and exhibitors are urged to secure their booth space early. More information on MEDICAL FAIR THAILAND 2017 can be found at www.medicalfairthailand.com About Messe Düsseldorf Asia Messe Düsseldorf Asia is a subsidiary of Messe Düsseldorf in Germany, one of the world’s leading trade fair organisers, responsible for organising more than 20 global No. 1 exhibitions in various industries including medicine and health, specifically MEDICA, COMPAMED and REHACARE INTERNATIONAL held in Düsseldorf, Germany. With extensive expertise in organising trade fairs in Southeast Asia, Messe Düsseldorf Asia has developed a portfolio of numerous trade fairs in the region since 1995. For more information, please visit mda.messe-dusseldorf.com For more information on the exhibition, please contact: Daphne Yeo Senior Project Tel: (65) 6332 9682 Tmedicalfair-asia@mda.com.sg`

Medical Device ASIA | November-December 2016 | 7


Tyromotion unveils its Virtual Reality vision for robotic rehabilitation at MEDICA 2016 • DIEGO - robotic arm rehabilitation - in combination with Virtual Reality. Robotics and Virtual Reality for faster stroke recovery. • Revised PABLO system - hand-arm rehabilitation - with new wireless and cognitive features. • First time presentation of virtual high-end rehabilitation room. • Complete innovative TYROSOLUTION concept available for testing and consulting. can be accessed via a Virtual Reality headset. This virtual room conveys in a memorable way to the fair-visitor how day-to-day therapy, aided by robotic- and computer based devices, looks like. Additionally, the user perceives the advantages by using the innovative TYROSOLUTION concept compared to conventional therapy solutions. The whole TYROSOLUTION concept is exhibited and fair visitors have the possibility to test the devices by themselves as well as to get professional consulting from Tyromotion employees.

Tyromotion, a world leader in rehabilitation technology has developed a novel rehabilitation device combining robotics and Virtual Reality for faster stroke recovery. Using Virtual Reality glasses and a bilateral 3D arm robot the patient emerges completely in a virtual world in which next to the visual also the physical environment can be shaped. This helps patients with limited arm function to perform exercises of daily living and to increase range of motion and repetition during training, both essential to motor learning. “The virtual reality component helps us to create a 3-dimensional training environment, which can be tailored exactly to the abilities of the patient and is extremely motivating due to the serious gaming component.” says Dr. Alexander Kollreider, CTO of Tyromotion. At Medica 2016, DIEGO will be shown in combination with Virtual Reality.

T

he company plans to introduce this new technology as soon as possible into the market so every patient suffering from a stroke can benefit from this new way of treatment. “Given the initial response from doctors and therapists we are confident that this novel approach 8 | November-December 2016 | Medical Device ASIA

can truly change the way we do therapy today. We will soon find virtual reality glasses in every living room and that should be the way to deliver motivating and cost effective therapy to everyone. Our new device is the first step into this near future.” adds David Ram, CEO of Tyromotion. At MEDICA this year, Tyromotion also presented its revised PABLO system. New wireless and cognitive features are added. The PABLO system is one the most successful products within the TYROMOTION portfolio. Tyromotion additionally presents for the first time its virtual high-end rehabilitation room which

Tyromotion GmbH is one of the world-wide leading manufacturers and distributors of robotand computer-assisted therapy units for the rehabilitation sector. The company focusses on the development of novel technologies based on the use of powerful mechatronic systems for rehabilitation. These systems help physicians and therapists to reach their goal of guiding their patients through the rehabilitation process faster and in a more motivating way. Today the innovative therapy units of Tyromotion GmbH are being used in rehabilitation centers and clinics world-wide. By now, the company with headquarters in Graz has additional branch establishments in Germany and the USA. The distribution network extends across the entire globe. www.tyromotion.com


Doctors Hospital At Renaissance Is First In Rio Grande Valley To Deploy Xenex Germ-Zapping Robots DHR enhances patient safety by deploying robots to destroy germs and bacteria that can cause infections

F As hospitals across the nation look for new and innovative ways to battle deadly pathogens and kill multi-drug resistant organisms that can cause Hospital Acquired Infections, Doctors Hospital at Renaissance Health System (DHR) has taken a leap into the future with the installation of seven Germ-Zapping Robots™ that destroy hard-to-kill bugs in hard-to-clean places. DHR is the first hospital in the Rio Grande Valley to tap into a technology that uses pulsed xenon ultraviolet (UV) light to quickly destroy bacteria, viruses, mold and other pathogens. 10 | November-December 2016 | Medical Device ASIA

rom doctors and staff to patients and visitors, hundreds of people enter a hospital daily, unknowingly escorting a host of contaminants and germs on their person. Enterovirus D-68, C. diff, MRSA, VRE – an alphabet soup of deadly pathogens lurk in the very place people go to get healthy. In demonstration of its commitment to keep patients safe, DHR has taken an important step into the future to zap dangerous superbugs and stop the spread of healthcare associated infections (HAIs). The seven Xenex robots at DHR use Full Spectrum™ pulsed xenon UV light to quickly destroy harmful bacteria, viruses, fungi and bacterial spores. The portable disinfection system is effective against even the most dangerous pathogens, including Clostridium difficile (C. diff), norovirus, influenza, Ebola and methicillin-resistant Staphylococcus aureus, better known as MRSA. “We aim to do everything possible to provide a clean environment at DHR to reduce the risk of hospital

acquired infections,” said Dr. Carlos Cardenas, DHR Chief Administrative Officer. “We have long been recognized as South Texas’s leader in medical technology and highly specialized care, so it’s only fitting that we should employ the same level of technological innovation when it comes to removing the pathogens that can cause infections.” Cardenas continues, “One hospital acquired infection is one too many, so we are excited to begin using the Xenex system to help us achieve our goal of zero infections. This investment is important and underscores our commitment to patient care and the communities we serve. Not only will these robots provide a cleaner environment for patients, but it also ensures an optimal environment for visitors and our employees.” The Xenex Full Spectrum UV room disinfection system works by pulsing xenon, an inert gas, at a high intensity in a xenon ultraviolet flashlamp. This produces intense ultraviolet C (UVC) light


which penetrates the cell walls of microorganisms, including bacteria, viruses, mold, fungus and spores. Their DNA is fused, rendering them unable to reproduce or mutate, effectively killing them on surfaces without contact or chemicals. The portable Xenex system can disinfect a typical patient or procedure room in five minute cycles without warm-up or cooldown times. It can be used in any department and in any unit within a healthcare facility, including isolation rooms, operating rooms, general patient care rooms, contact precaution areas, emergency rooms, bathrooms and public spaces. The Xenex Germ-Zapping Robot has been tested and proven using independent lab verification on the most common, dangerous and difficult-to-treat microorganisms. Most importantly, the Xenex system has been credited by health care facilities across the U.S. for helping them reduce their infection rates significantly. Xenex Germ-Zapping Robots are backed by published, peer-reviewed patient outcome studies. The devices are mercuryfree, which is beneficial for the

hospital and the local environment. More than 350 hospitals, Veterans Affairs (VA) and DOD facilities nationwide are using the system with the purpose of reducing rates of infection and saving costs. And it’s safe. Because the light is extremely intense, the machine operates on its own once it’s set up in a room. For enhanced safety, a sign placed outside the door warns people not to enter, and a motion sensor automatically shuts off the machine if someone should enter. With germ-zapping robots on the EVS team, DHR is proud of its commitment to patient safety. Explains Director of Infection Control, Mary Lou Love, MSN, RN, “We already have a strong infection prevention program in place. This robot is helping us be more effective at eradicating the superbugs that pose a threat to patients, their families and our staff.”

cleaning operations. Xenex’s mission is to save lives and reduce suffering by eliminating the deadly microorganisms that cause hospital acquired infections (HAIs). The company is backed by well-known investors that include Malin Corporation, Battery Ventures, Targeted Technology Fund II and RK Ventures. For more information, visit Xenex.com.

Doctors Hospital at Renaissance Health System From general acute care services to individually-tailored wellness and preventative health programs, at Doctors Hospital at Renaissance (DHR) over 700 physicians and more than 1,500 nurses dedicate themselves to offering a full continuum of care in over 70 different sub-specialties. DHR is a 513-bed physician-owned health system that offers some of the most comprehensive medical care on the U.S. Southern Border. For more information, please call (956) DOCTORS (362-8677) or visit our website at www.dhr-rgv.com. For more information on Doctors Hospital at Renaissance’s clinical certifications, please contact Irene Ochoa, Director of Clinical Certification.

Xenex Disinfection Services Xenex’s patented Full Spectrum pulsed xenon UV room disinfection system is used for the advanced disinfection of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital Medical Device ASIA | November-December 2016 | 11


Shri CH.Vidyasagar Rao, Hon’ble Governor of Maharashtra and Shri Devendra Fadnavis, Hon’ble Chief Minister of Maharashtra inaugurate

Apollo Hospitals - a World-class Super-Speciality Tertiary Care Hospital in Navi Mumbai

The state of the art, contemporary superspeciality tertiary care hospital Apollo Hospitals in Navi Mumbai was formally inaugurated by Shri CH. Vidyasagar Rao, Hon’ble Governor of Maharashtra & Tamil Nadu in the august presence of guest of honour Shri Devendra Fadnavis, Hon’ble Chief Minister of Maharashtra. Dr. Deepak Sawant, Minister of Public Health and Family Welfare, Maharashtra was also present on this occasion. 12 | November-December 2016 | Medical Device ASIA

A

pollo Hospitals in Navi Mumbai is the 66th hospital in the pioneering group’s network. Speaking on the occasion, Shri CH.Vidyasagar Rao, Hon’ble Governor of Maharashtra & Tamil Nadu said “I am delighted to inaugurate Apollo Hospitals in Navi Mumbai, a worldclass healthcare facility with clinical and technological advancements on par with global standards; it is well poised to serve the people of Maharashtra. I congratulate Dr Prathap C Reddy, Chairman, Apollo Hospitals for transforming the landscape

of Indian healthcare.” Shri Devendra Fadnavis, Hon’ble Chief Minister of Maharashtra said “Apollo Hospitals in Navi Mumbai is the most advanced hospital in this region and it will address the medical needs of our people. I do laud Dr Prathap C Reddy, Chairman, Apollo Hospitals for launching a hospital of truly international standards in the region. The people of Maharashtra will be benefitted by this hospital and it will certainly also motivate patients from across India and other countries to come here


Theatres, 3 Cath Labs, 69 consultation suites, superior 5-bed standard units, spacious single rooms and 4500 sq.ft.of presidential suites.

About Apollo Hospitals

for advanced medical treatment. Dr Prathap C. Reddy, Chairman, Apollo Hospitals said “Our mission is to bring healthcare of international standards within the reach of every individual and since our inception in 1983, we have been honoured with the trust of almost 50 million people who came to us from across 121 countries. Now, Apollo Hospitals in Navi Mumbai, a worldclass tertiary care hospital will serve the people of Maharashtra and also patients who come to India looking for high quality medical care at an affordable cost. With over three decades of clinical acumen, established protocols and proven expertise, Apollo Hospitals will set new benchmarks in healthcare delivery and patient experience in Maharashtra.” Dr Narendra Trivedi, CEO, Apollo Hospitals, Navi Mumbai said, “Navi Mumbai and the surrounding region has been developing at a rapid pace and yet one has had to travel a great distance to access high quality medical care. Now with Apollo Hospitals in Navi Mumbai, an international standard of medical facilities will be accessible to all. Moreover, being in proximity to the Mumbai-Pune expressway, the hospital has geared itself to provide advanced emergency care within the critical golden hour. The hospital has a 17 bedded emergency ward, 120 bedded ICU and 24*7 Emergency medical Services.”

Apollo Hospitals in Navi Mumbai is equipped with highly advanced diagnostics including AlluraClarity Cath lab – the most advanced Cath lab in India, Digital Mammogram, X-ray stereotactic biopsy, 3 Tesla MRI and more. The hospital will provide comprehensive services in major specialities including, Cardiology, Orthopaedics & Joint Replacements, 24*7 Emergency & Critical Care services, General Medicine, General & Laparoscopic Surgery, Bariatric & weight loss surgery, Nephrology & 24x7 Dialysis, Urology, Neurology, NeuroSurgery, Plastic & Cosmetic Surgery, Pulmonology, Medical & Surgical Gastroenterology, Anaesthesiology, ENT, Obstetrics & Gynaecology, Paediatrics, Radiology and Pathology. Soon, Solid Organ Transplant (Live and Cadaver) and Medical Oncology & Surgical Oncology will be established in Apollo Hospitals, Navi Mumbai. Each of these departments is led by highly experienced and skilled doctors, educated and trained at the foremost medical institutions of UK, USA and India. The nursing services and the patient-care providers are specially trained to provide compassionate care round-the-clock. Spread over 7,00,000 sqft Apollo Hospitals, Navi Mumbai houses more than 50 specialties, equipped with state-of-the art equipment and offers multi- disciplinary high-end tertiary care. The 500-bedded super specialty hospital is equipped with cutting edge technology, 14 Operating

It was in 1983, that Dr. Prathap Reddy made a pioneering endeavour by launching India’s first corporate hospital Apollo Hospitals in Chennai. Over the years Apollo Hospitals has established itself as home to the largest cardiac practice in India with over 160,000 cardiac surgeries. Apollo Hospitals is also the world’s largest private cancer care provider and runs the world’s leading solid organ transplant program having conducted over 1,500 solid organ transplants in 2014-15 alone. Now, as Asia’s largest and most trusted healthcare group, its presence includes 9,554 beds across 69 Hospitals, 2,326 Pharmacies, over 172 Primary Care and Diagnostic Clinics, over 148 Telemedicine Centres and more than 80 Apollo Munich Insurance branches panning the length and breadth of the country. As an integrated healthcare service provider with health insurance services, projects consultancy services, medical education centres and a Research Foundation with a focus on global clinical trials, epidemiological studies, stem cell & genetic research, Apollo Hospitals has been at the forefront of new medical breakthroughs with the most recent investment being that of commissioning the first Proton Therapy Centre across Asia, Africa and Australia in Chennai, India. In a rare honour, the Government of India issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For more than 33 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Our hospitals are consistently ranked amongst the best hospitals globally for advanced medical services and research.

Medical Device ASIA | September-October 2016 | 13


Partnership between the University of New South Wales, Australia and Apollo Medvarsity to offer new international program to train India’s next generation of public health leaders Apollo Hospitals Group Chairman Dr Prathap Reddy to be awarded an honorary Doctorate of Medicine from UNSW [The last person to receive this honour from UNSW was Nelson Mandela] • Partnership between the University of New South Wales, Australia and Apollo Medvarsity will see a new UNSW Master of Public Health (International) program offered in India • Specialist postgraduate program will help address India’s shortage of public health professionals and strengthen the country’s capacity to respond to major health challenges • Apollo Hospitals Group Chairman Dr Prathap Reddy to be awarded an honorary Doctorate of Medicine from UNSW, conferred by President and Vice-Chancellor Professor Ian Jacobs.

A University of New South Wales (UNSW) public health degree to be launched today is designed to strengthen the capacity of India’s medical workforce to respond to the major health challenges facing the country.

T

he partnership between UNSW Australia and Apollo Medvarsity, will see a new Master of Public Health (MPH) International program offered in a fully-online mode in India for the first time. The Apollo Hospitals Group includes 64 hospitals and 1500 pharmacies as well as several hundred primary care and diagnostic clinics. UNSW is a top ranked global university. The degree will be offered through UNSW Medicine, which is in the top 50 medical schools in the world. The need for this degree was identified by Apollo Hospitals Group’s e-learning venture Apollo Medvarsity, who have been delivering joint courses in other subjects with UNSW for several years. The new degree, aimed at doctors and other health professionals, will be delivered and awarded by UNSW, with an internship in an Apollo health site to give students the chance to apply theory in practice in India. Indian students will join fellow health professionals from Australia and around the world in a virtual global classroom, learning essential public health theory and skills. A coveted internship will be at the Total Health Program in drought-stricken Aragonda, the birthplace of Dr PC Reddy, Apollo’s founder. “Total Health aims to prevent disease and build healthy, resilient communities,” said Dr Reddy, the program’s founder. He also added that “Non communicable disease is going to be the number 1 reason for mortality in India. A strong community and public health program will help doctors and hospitals be better prepared to deal with NCD’s. Our partnership with UNSW will allow us to bring the best training available anywhere in the world on managing public health and offer it to our students in India.” “We are delighted to bring this program to the next generation of health leaders in India through the Master of

14 | November-December 2016 | Medical Device ASIA

Public Health (International).” SPHCM Head of School, UNSW Professor Raina MacIntyre, said India faces a shortage of public health professionals as it responds to population level control of major diseases including diabetes, cancer and infectious diseases. “The new Master of Public Health (International) will help address the growing shortage of public health professionals in India. The flexible program is delivered fully online so that busy clinicians can keep working as they achieve this qualification,” Professor MacIntyre said. “They can retain their job and avoid the expense of living in Australia, and get a UNSW degree, while still attending our summer school in Sydney.” Chairman of the Apollo Hospitals Group, Dr Prathap Reddy, will be awarded an honorary Doctorate of Medicine by UNSW at the launch of the new course, in recognition of his eminent service to medicine in India and worldwide. UNSW President and Vice-Chancellor Professor Ian Jacobs, who will present the honorary degree, said both organisations have common values and a shared commitment to creating a better world through improving healthcare. “The new masters program reflects these shared goals and builds on our considerable mutual strengths in health and education. I look

forward to growing these enduring links between Australia and India,” Professor Jacobs said. Students enrolled in the Master of Public Health (International) course will have access to advanced learning tools and technology with a fully comparable experience to face-to-face learning. “We have a huge demand for online learning, and in a rapidly changing world this is the future of education,” said Dr Padmanesan Narasimhan, Program Director, Master of Public Health (International). “UNSW and Apollo Medvarsity have both recognised this need, and our partnership brings together the very best of both institutions to improve the public health workforce in India,” Dr Narasimhan said. “At Apollo and Medvarsity we are always looking for the best education partners that can add value to our doctors and healthcare professionals. This partnership between Apollo Medvarsity and UNSW brings an exceptional, globally recognised masters program to India. Through this course, our students can also apply for jobs with global organizations including the WHO, UNESCO, etc.” said Ms. Sangita Reddy. Job opportunities for graduates of this program may include positions in governments and health systems worldwide, as well as at the World Health Organization and other international NGOs.


THOMAS 2380 Versatile Pressure/Vacuum Pump

Japan: Shiko +81 90 8051 5394

shiko.iwai@gardnerdenver.com | China: Mark +86-135-0170-935

eddie.lee@gardnerdenver.com

michelle.wu@gardnerdenver.com mark.lou@gardnerdenver.com

keri.mcneill@gardnerdenver.com | Korea: Eddie +82 10 7720 2584

manoj.ahire@gardnerdenver.com | SE Asia: Michelle +852 9170 0693

Australia: Keri +61 (0) 402 275 962

India: Manoj +91 9004282345

B/404, 4th Floor , Kedarnath, opp. Gokulanand Hotel,Western Express Highway, Dahisar (E) Mumbai – 400 068. T: +91 22 658 12345 | F: +91 22 289 20224

Gardner Denver Engineered Products India Pvt. Ltd

provides long-life reliability with low vibration and quiet operation.

x 6.73” (171 mm) high. Its compact design, makes it ideal for use in various applications, while the twin-cylinder design

and has a one-piece monolithic head. Weighing 12 pounds, the 2380 is 9.31” (236.5 mm) long x 5.14” (130.6 mm) wide

The 2380 provides 100 psi (6.9 bar) max pressure with open flow of 2.3 cfm (65 l/min). The new 2380 series is fan-cooled

including medical, dental, industrial packaging/printing, and environmental in pond aeration.

The 2380 series air compressors are designed for pressure/vacuum and high flow, with suitability for a range of applications

New Platform, Large Twin-Cylinder Pump with WOB-L® Technology

THOMAS 2380 VERSATILE PRESSURE/VACUUM PUMP


Study tour to Indonesia – Cross learning from best practices on Family Planning

A

delegation of Indian members of parliament, senior representatives of the Ministry of Health and Family Welfare-Government of India, senior representatives of NITI Ayog (National Institution for Transforming India) concluded a study tour to Indonesia hosted by Population Foundation of India. The objective of the visit was to learn from Republic of Indonesia’s initiatives and best practices in the provision and access to family planning services and methods. The study tour enabled learning from successful government interventions and the work done by the BKKBN (National Family Planning Coordinating Board) in the country. Indonesia has demonstrated success in optimising method mix in contraceptive methods, reaching rural areas, building private sector selfreliance and improving quality of care in family planning. This has helped the country to attain 60% mCPR. With the increased use of modern contraceptive methods, Total Fertility Rate (TFR) of the country which was 5.9 in late 1960s, dropped to 2.6 in 2012. This also led to increase in birth intervals.  The country’s unmet need for family planning is only 11%, demonstrating the success of Indonesia’s family planning programme, hence making it an ideal site for the study tour. The study tour was an important endeavor in light of India’s strides towards achievement of its vision to improve and prioritise family planning and maternal health. In the London Summit of 2012, the Indian Government was a part of the 69 nations that committed to achieve a global march to make family planning a reality. This global coalition, known to us as FP2020 is an important milestone that requires collective participation and collaboration of stakeholders including civil society organisations, parliamentarians, government and the media. The recent impetus to achieve India’s family planning vision has been supported by the Government of India’s initiative to include additional birth spacing methods to the basket of contraceptive choices available. These methods, especially injectable contraceptives mark over 60 per cent of Indonesia’s modern Contraceptive Prevalence Rate (mCPR) and the tour showcased specific community level engagement that has led to this positive trend. Dr S K Sikdar, Deputy Commissioner, Family Planning, MoHFW-GoI said “The Ministry of Health and Family Welfare, GOI, is fully committed to provide the people of India, access to quality family planning services, with special emphasis on modern spacing methods. We are already working to ensure the smooth roll out of injectable contraceptives, centchroman and progestin only pills as additional birth spacing methods. The study tour to Indonesia provided an opportunity to see the actual usage of implants in the public health facilities and the ease with which insertions were being done. GOI would explore the possibility of introducing implants and further increasing the basket of choice” 16 | November-December 2016 | Medical Device ASIA

As an organization committed to the cause of women’s reproductive and health rights, Population Foundation of India sees Family planning as embedded within the reproductive rights framework and very closely linked to maternal and child health indicators. The study tour to Indonesia was a significant step in strengthening the engagement of parliamentarians, policy makers and senior government officers along with champions of women’s health. The high-level delegation from India is committed to carry forward the learning and best practices for policy and program recommendations based on India’s health indicators. There needs to be sustained public discussion and collaborations using PPP and other models to underline and supplement existing government efforts. Dr Sanjay Jaiswal, Member of Parliament from Pashchim Champaran Bihar and the convenor of the Forum for Parliamentarians for Health and Family Planning emphasised that “It is inspiring to learn from the great strides Indonesia has made in family planning and maternal health indicators. The protection that implants provide at a very low cost and the ease of insertion of implants, leads me to believe that India should add it to the existing basket of spacing methods” Ms Poonam Muttreja, Executive Director-PFI said that “PFI is honoured to have hosted this high-level delegation. We are encouraged by the study tour and the cross learning between the BKKBN, community centric programmes in Jakarta and Lombok, and the esteemed members of parliament from both India and Indonesia. We are committed in supporting

the Government of India and our representatives in sustained dialogue for mutual learning and implementation of best practices.” The delegation included Dr Sanjay Jaiswal, MP from Pashchim Champaran, Bihar, Dr Heena Gavit, MP from Nandurbar, Maharashtra, Dr Kirit Premjibhai Solanki, MP from Ahmedabad, Gujarat, Mr Sudheer Gupta, MP from Mandsour, Madhya Pradesh and Mr P D Rai, MP from Sikkim apart from Dr SK Sikdar Deputy Commissioner, Family Planning, MoHFW-GoI, Mr Sumant Narain- Director, Health, NITI Ayog. Senior team from PFI included Ms Poonam MuttrejaExecutive DirectorPFI, Dr Sujeet Ranjan Programme Director- PFI.

About Population Foundation of India (PFI) Population Foundation of India is a national NGO, which promotes and advocates for the effective formulation and implementation of gender sensitive population, health and development strategies and policies. The organization was founded in 1970 by a group of socially committed industrialists under the leadership of the late JRD Tata and Dr Bharat Ram. PFI addresses population issues within the larger discourse of empowering women and men, so that they are able to take informed decisions related to their fertility, health and well-being. It works with the government, both at the national and state levels and with NGOs, in the areas of community action for health, urban health, scaling up of successful pilots and social and behaviour change communication. PFI is guided by an eminent governing board and advisory council comprising distinguished persons from civil society, the government and the private sector.


Swami Advdeshanand Giri ji Maharaj announces setting up of Nayati Pediatric foundation - Swami ji to fund 101 paediatric cardiac surgeries at Nayati hospital, Mathura His Holiness Swami Avdeshanand Giri ji Maharaj today announced the formation of Nayati Pediatric Foundation which will aim at spreading awareness about both preventive health and acute medical conditions in children but also providing underprivileged children with specialized pediatric treatment. We believe through our expertise and efforts we can transform the future of our children and our nation.

care and it will be our endeavour that no needy child remain untreated because of economic reasons.” She further added. A committee has been formed which will evaluate the financial health of the family and only post due diligence discount full or partial will be offered to the family of the patient. It will be a completely transparent process.

In India, an increasing number of children and young adults under 18 years of age are suffering from life threatening diseases and conditions. These numbers are especially high in tier 2 & tier 3 cities and in most cases these young patients need dedicated and prolonged treatment, something which their families and parents with limited incomes cannot afford. For them, these factors make proper care and healing a distant dream. With the idea of tackling this relevant issue, Swami Avdeshanand ji and Nayati Healthcare have launched ‘Nayati Pediatric Foundation’. The foundation will ceaselessly work on cardiac care, Oncology and critical neonatal care. On the occasion, Swami Avdeshanand Giri ji Maharaj, Chairman, Nayati Pediatric Foundation stated, “Humans are the finest creation of God and children are the pillars of any country. They are the future of our country. Children will shape our Nation’s narrative and drive our progress, and it is our duty to ensure our future generations live long healthy lives. Through the foundation, we intend to expand access to quality health care for those who due to paucity of funds can-not afford good healthcare. The physical and mental health of our children represents the strength of the country so it should be the prime concern of the society. I am happy to announce free cardiac surgeries of 101 children at Nayati Hospital, Mathura. This is just a beginning and I am confident that in the months to come this will grow from hundreds to thousands. ” Niira Radia, Chairperson, Nayati Healthcare stated “With great humility, I thank Swamiji for his generosity and am grateful for his support. India has the largest burden of heart disease among children with about 2 lakh children born every year with some form of a congenital heart defect (CHD). This number is far greater than the number of children with the condition, and is growing in the country. In Uttar Pradesh, where Nayati hospital’s first flagship 351 beded super speciality hospital is, we have seen large number of children with cardiac and cancer disease which require dedicated and at times prolonged treatment. In some cases, parents have very meagre paying capacity and despite our best efforts to minimise the cost of treatment there is significant financial burden on the families. Our vision is to provide efficient cardiac and cancer treatment to financially unprivileged. “The process of quality care to reach all is an integrated approach. It needs like-minded philanthropic and generous donors to come together to provide quality of life to our future generations. Children being the most precious wealth of our nation deserve the best available treatment and

About Nayati Healthcare & Research Pvt. Ltd., taking treatment to the patient: Nayati Healthcare& Research is India’s first healthcare organisation offering premium tertiary care to Tier-II & Tier-III cities. It offers world class patient care services aided by state-of-the-art medical technology and advanced treatment facilities. The aim of the organisation is to provide cost effective and easily accessible healthcare. About Nayati Multi Super Specialty Hospital, Mathura: Nayati Multi Super Specialty Hospital, Mathura is the first hospital in the region to provide integrated, comprehensive and high quality healthcare through our Centres of Excellence. These centres are supported by advanced Intensive Care units comprising of: MICU, CCU, SICU, NICU and PICU. The hospital caters to not just the people of Mathura but also Vrindavan, Agra, Palwal, Firozabad, Mainpuri, Kasganj, Etawah, Etah, Hathras, Aligarh and surrounding areas. Medical Device ASIA | November-December 2016 | 17


MEDICAL FAIR THAILAND 2017 The Region’s Most Complete Medical & Healthcare Exhibition Returns!

6 – 8 September 2017, QSNCC, Bangkok, Thailand The 8th edition of the international exhibition on Hospital, Diagnostic, Pharmaceutical, Medical & Rehabilitation Equipment & Supplies continues its proud tradition of show-onshow growth, with an expected international participation of 700 exhibitors, 17 national pavilions and country groups as well as an anticipated attendance of 8,500 qualified trade buyers and decision makers from across Asia. Creating an international marketplace that allows global companies to access a targeted audience is MEDICAL FAIR THAILAND’s strongest suits that have contributed to making it one of the most influential shows on the region’s medical and healthcare trade calendar. In 2017, MEDICAL FAIR THAILAND will take place at the Queen Sirikit National Convention Centre in Bangkok, from 6 - 8 September. 18 | November-December 2016 | Medical Device ASIA

What to Expect in 2017? In the spotlight at MEDICAL FAIR THAILAND 2017 are two special platforms in the areas of Rehabilitative Care and Connected Healthcare. Complementing these dedicated showcases will be a suite of co-located conferences, technical seminars and themed workshops presented by key thought leaders and industry experts in their respective fields, involving delegates, visitors and exhibitors in meaningful discussion on the future of health care. Among them is ARTeC 2017, returning for the 3rd edition, the Advance Rehab Technology Conference, will emphasise innovative and effective technological solutions that could

decrease mobility-related disability, reduce related complications and improve quality of life.

Connecting Healthcare Innovations with Medical Professionals An unparalleled opportunity to showcase your latest products and build invaluable relationships with key industry players from around the globe. Be part of MEDICAL FAIR THAILAND 2017 and tap into the region’s burgeoning growth potential. Gain access to Southeast Asia’s dynamic medical and healthcare market. Bookings for exhibitor spaces are now open!


For more information, visit medicalfair-thailand.com

About the Organiser Organised by Messe Düsseldorf Asia, MEDICAL FAIR THAILAND is the region’s number 1 event for the medical and healthcare industry, bringing together all facets of the industry for networking, sharing of best industry practices, as well as products, services and solutions development. Part of

MEDICA – World Forum for Medicine, a global series of medical events, MEDICAL FAIR THAILAND’s contribution and growing relevance to the region and its associated industries is further underlined by the endorsement and continued support it receives from hospitals and medical associations all across Asia as well as from the Ministry of Public Health Thailand and the Thailand Convention and Exhibition Bureau. For more information, please visit mda.messe-dusseldorf.com

Medical Device ASIA | November-December 2016 | 19


MTA2017 to spotlight new technologies with specialised zones

In a global manufacturing outlook report, 49 per cent of manufacturers surveyed were reported to be investing six per cent of their revenues in R&D and innovation, in a push to transform their businesses. Asian manufacturing companies surveyed exhibited the highest investment expectations, with a majority of respondents from China, Japan and India indicating they would spend more than six per cent of their revenues on technology and innovation. 25 per cent of the respondents have already poured investment in avant garde technologies such as 3D printing. Riding on a wave of renaissance in the industry, MTA2017 – Asia’s premier manufacturing technology industry event returning from 4 to 7 April at the Singapore Expo, will kick off a host of new features - The Optics & Photonics Innovation Hub, The Semiconductor Innovation Centre, and a 3D Printing Seminar. “As manufacturing continues to evolve and value creation has become 20 | November-December 2016 | Medical Device ASIA

an integral component of the change process, many traditional manufacturing businesses in the Asian region need to become agile and embrace change. The new features, along with the recurring Capabilities Hub, are designed to serve industry players who are looking to leverage on technology and innovation to maintain their market leadership and stay ahead of the change curve,” says Mr. William Lim, Project Director of Machinery Events at Singapore Exhibition Services, organiser of MTA2017. Lim adds, “More importantly, the newfound knowledge and skillsets will ensure that

companies and their workforce will be well-positioned for growth opportunities in the new manufacturing era.”

MTA2017: Spotlighting advanced technologies for high-value manufacturing Optics & Photonics Innovation Hub In collaboration with the Optics and Photonics Society of Singapore (OPSS), LUX Photonics Consortium and The Photonics Institute, the Optics and Photonics Innovation Hub is dedicated to showcasing products and services in the field of optics and photonics. This specialised zone will bring together industry and academic leaders,


manufacturers and suppliers to showcase the latest research and innovative products. Soda Vision, Del Mar Photonics / Team Photon Inc, Wavelength Opto-Electronic, Sintec Optronics and PI (Physik Instrumente) Singapore are among some of the confirmed exhibitors in the zone. “MTA is a wonderful platform for both local and international industry players in optical engineering to share knowledge, network and support one another in the region. The Optics and Photonics Society of Singapore (OPSS) is pleased to participate in MTA2017 in the Optics and Photonics Innovation Hub, as well as organise the icOPEN2017 conference. Through these initiatives, we hope to continue building and reinforcing the connections between industry and academia,” says Professor Anand Asundi, Chairman of OPSS. “The LUX Photonics Consortium’s main objective is to bring industry and academia together to collaborate on photonics research and innovation, and provide access to our member companies to global photonics research and industry network. MTA is one of the most established events that gather companies in various vertical segments of the market which are enabled by photonics technologies. Our participation in setting up the Optics & Photonics Innovation Hub provides a platform for our member companies to showcase their products and services in the optics and photonics sector, and expand their industry and business networks effectively,” adds Professor Tjin Swee Chuan, Chairman of LUX Photonics Consortium. Some member companies of LUX Photonics Consortium confirmed to be participating at MTA include Finisar Singapore, Einst Technology, Hylax Technology, II-VI Singapore,

D’Optron, Tip Biosystems, Lighthaus Photonics and Hillhouse Technology. Semiconductor Innovation Centre According to the World Semiconductor Trade Statistics (WSTS), the worldwide semiconductor market is expected to increase 2 per cent in 2017 and 2.2 per cent in 2018. At MTA2017’s Semiconductor Innovation Centre, visitors can get up close and personal with advanced semiconductor manufacturing technologies and solutions made for the evolving global electronics market, and learn how harnessing these technologies and solutions will enable the industry to compete in the global market. Some companies on board include Sandvik South East Asia, ISO-Dynamique Microsystems and Onn Wah Tech. 3D Printing @ MTA Advances in additive manufacturing, or 3D printing as it is commonly known, have seen the application of more and more materials to the process and the creation of innovative solutions for the manufacturing industry. Besides a 3D Printing Technology Tour, a new 3D Printing Seminar will be held to impart technological updates, opportunities, issues and challenges impacting the industry. The National Additive Manufacturing Innovation Cluster and the Additive Manufacturing Innovation Centre by Nanyang Polytechnic will be featured on the show floor. Capabilities Hub A centrepiece at MTA, the Capabilities Hub gathers local parts and component manufacturers and service providers to highlight their manufacturing competencies in the high-value sectors of Aerospace, Complex Equipment, Medical Technology and Oil & Gas. Organised in partnership with the

Singapore Institute of Manufacturing Technology (SIMTech), this area will see local and overseas players converge to network, exchange knowledge, discuss potential collaborations and forge partnerships. Confirmed exhibitors include CEI Limited, Microcast, Eratech, Solidmicron Technologies, Nano Technology Manufacturing, Onn Wah Precision Machining, Fujicon Engineering, Autec Solutions, ST Kinetics Integrated Engineering, JEP Precision Engineering and Wah Son Engineering, to name a few.

MetrologyAsia2017: Serving industry’s demands for precise engineering Metrology solutions are important to the manufacturing process, from miniature electronics, intricate medical devices and precision components to large aircraft structures and oil & gas parts. MetrologyAsia2017 is dedicated to showcasing cuttingedge metrology and inspection equipment and spotlighting companies specialising in high-end test and measurement apparatuses and systems. Attendees will learn

about the latest in metrology solutions from the top technology providers around the world.

Conferences for knowledge and skills upgrade In a rapidly changing business landscape, having the right information at the right time is essential to business sustainability and success. With knowledge sharing being a vital element, the conferences at MTA2017 are specially formulated to enhance industry professionals’ insights in new manufacturing concepts. The Smart Manufacturing Asia conference will have industry thought leaders and experts delving into pertinent topics and offering practical tips in digital manufacturing, Industry 4.0, robotics and industrial automation. The Precision Engineering Centre of Innovation (PE COI) Annual Conference and the International Conference on Optical and Photonic Engineering (icOPEN), both having seen highly successful editions, will return to debate on latest trends and issues facing the precision engineering industry.

MTA2017 - Manufacturing Technology Asia (held alongside MetrologyAsia2017) at A Glance: Incorporating: iAutomation2017, MetalAsia2017, Outsource&SubCon2017, ToolTec2017 Date: 4 – 7 April 2017 (Tuesday - Friday) Venue: Singapore Expo Opening Hours: 10.30am to 6pm daily Admission: Business and trade professionals Website: www.mta-asia.com Visitor registration: www.mta-asia.com/to-visit/visitor-pre-registration/

About Singapore Exhibition Services Pte Ltd Singapore Exhibition Services organises a portfolio of international tradeshows serving the Communications, Engineering, Machinery and Lifestyle industries. Our events consistently attract a high level of overseas participation with foreign exhibitors accounting for almost 80% of the show floor. Singapore Exhibition Services is a member of Allworld Exhibitions Alliance, a global network with over 50 offices worldwide. Please visit www.sesallworld.com for more information. Medical Device ASIA | November-December 2016 | 21


International Medical Devices and Supplies Fair Concludes More than 10,000 Buyers Joined the Fair

T

he seventh HKTDC Hong Kong International Medical Devices and Supplies Fair concluded its successful three-day run today. Organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA), the fair welcomed more than 10,000 buyers, a slight increase of 1.2 per cent over the previous year. “With the advancement in medical technologies and the global trend of an ageing population, there is immense growth potential in the medical supplies and products market,” said HKTDC Deputy Executive Director Benjamin Chau. “The Medical Fair showcased a wide selection of medical supplies and attracted exhibitors and buyers from all over the world. This year, buyer attendance from such places as the United States, Malaysia, the Philippines, Thailand and Singapore recorded satisfactory growth, an indication of the Asian market’s flourishing demand for medical products and services.”

Strong demand in the silver market The United Nations estimates that, by 2050, there would be 2.1 billion people aged 60 or above, accounting for 25 per cent of the world’s population. This trend has boosted demand for healthcare products tailored to elderly care and rehabilitation and buyers at the Medical Fair were keen to source such products. Eyeing the massive business opportunities related to the silver market, Delta Pyramax Engineering Ltd. from Hong Kong, which previously specialised in the building-related materials business, has extended its scope to include the distribution of medical devices over the past decade. At the fair this year, the company displayed an electric and ergonomic toilet aid from the Netherlands, designed for the elderly and patients with limited mobility. Webby Lau, the company’s Marketing Manager said, “Our company has been participating in the Medical Fair for the past few years. Traffic is good at this year’s fair. We have met many potential customers whose response to elderly products was better than last year. We will continue to explore business cooperation with these new contacts in the hope of establishing long-term relationships with them.” 22 | November-December 2016 | Medical Device ASIA

There is a growing trend of people at an early age being diagnosed with dementia. Hong Kong’s Janley Ltd. showcased its German Memoriana Dementia Room Concept at its debut exhibition this year. This room-setting service can simulate a patient’s home environment in a hospital room with rehabilitation features added to the room’s furnishings. The company’s Managing Director, Jeffrey Tai, said, “There is a growing demand for elderly home care and rehabilitation products. Many local hospitals and elderly homes have come to us and expressed strong interest in our products. We are in talks with a number of new and existing customers to develop business opportunities and we are positive about growth in the elderly medical supplies market.”

Household medical products sought after This year’s Medical Fair welcomed more than 260 exhibitors from 12 countries and regions. Fifteen product zones showcased a variety of healthcare equipment, products and services and provided an important business platform for the healthcare industry. Household medical products and services are becoming more common. Hong Kong exhibitor Illies East Asia Ltd. exhibited its mobile

electrocardiograph (ECG) device. By simply placing the device on the user’s finger or chest, it can take an ECG reading in just 30 seconds. The records can also be shared with medical professionals immediately via a mobile app. Sebastian Behler, Illies’s Department Director, Healthcare Technologies, said, “We’ve received strong enquiries from a lot of buyers from different places about this product, including buyers from Hong Kong, the Chinese mainland, India, Malaysia and Ireland. Some of them have bought samples from us. The results are very encouraging and we are positive about the prospects for further business development.” A first-time exhibitor APL Group Pty Ltd. from Australia sells and distributes healthcare and medical equipment in Australia and the Asia Pacific region, with a focus on automated external defibrillators (AEDs). General Manager Julian Cosgrave said the Medical Fair has helped his company explore the Hong Kong and Asia Pacific markets. “Many buyers have expressed keen interest in our products, including those from Hong Kong, India, Pakistan and the Philippines. The fair really opens up business opportunities and increases the industry’s awareness


about AEDs.” Mr Cosgrave said the Medical Fair has successfully brought together a large number of buyers and he was very impressed with the results. He hopes to return to the fair annually to grow the brand’s presence in the region. Also making its debut at the fair was Sweden’s ENTpro AB, a manufacturer and supplier of medical devices sold in Europe, the US and Japan. The company spotlighted a series of devices for people suffering from nasal allergies. These included a nasal rinsing devise and an innovative solution to stop snoring. Peter Ahnblad, Founder of ENTpro AB, said he considered the Medical Fair helpful for companies entering the Asian markets and particularly Hong Kong. He said, “We have received overwhelming responses from retailers and distributors enquiring about our products, including buyers from Hong Kong, Malaysia, Singapore and the Chinese mainland. At least four Hong Kong companies have expressed interest in distributing our products. We will decide on the right partners going forward.” Xiangxue Pharmaceutical Co., Ltd. is a high-tech medical and pharmaceutical company based in Guangzhou, coming to source at the fair. The company specialises in manufacturing Chinese medicine and medical research. Engineer Shi Zhi Wei said the company was actively expanding in the fields of life science and precise medical treatment. They joined the fair to

find new products and learn about the latest market trends. “We are interested in the advanced bone cement exhibited at the Hong Kong Science and Technology Parks Corporation booth,” Mr Shi said. “We also hope to explore cooperation opportunities with The Chinese University of Hong Kong in the research and development of wound dressings. The fair has brought together a selection of advanced medical equipment and products and provided the industry with a great opportunity to exchange ideas.”

Immense business opportunities in Southeast Asia Southeast Asia represents a massive market, and buyer attendance from the region was satisfactory. Concoll Inc. is a medical equipment distributor in the Philippines that provides advanced medical equipment to various government institutions and hospitals in the country. John Barry A. De Jesus, CEO, visited the Medical Fair for the first time this year. “We have found a number of exhibitors from Korea, Hong Kong and the Chinese mainland and talked to them about supplying medical devices such as ECG equipment and video laryngoscopes. I am very positive about placing orders with them.” India’s Biomed Healthtech (P.) Ltd. is an importer and distributor of overseas high quality medical equipment in India. Mukesh Daftary, the company’s President, pointed out that India’s ageing population had boosted the

country’s demand for elderly products. He said the company had come to the fair to look for different home care and rehabilitation products. “I have found more than 10 suppliers from the Chinese mainland and will be getting more product information and pricing details from them. We will then conduct market research to test the response of consumers. Initial orders may range from several thousand US dollars to US$10,000 for each product. If sales are positive, bigger orders will be made.” To help industry professionals garner market intelligence and expand their business networks, the HKTDC organised a series of seminars, forums and workshops during the Medical Fair to examine topics ranging from the latest industry developments to international regulations for medical devices. The Hospital Authority Convention 2016 was also held alongside the Medical Fair, creating more opportunities for interaction between industry players. The conference was attended by more than 5,000 healthcare professionals. Also held in parallel with the Medical Fair was the Asia Biotech Invest Conference, which offered biotech companies in the Asia Pacific region a platform for cooperation and information exchange.

8th Hong Kong International Medical Devices and Supplies Fair 16-18 May 2017, Hong Kong Convention and Exhibition Centre, Hong Kong For more information, please visit: www.hktdc.com/ex/hkmedicalfair/96 Medical Device ASIA | November-December 2016 | 23


Sharp’s Revolutionary Air Purifiers Helps Prevent Airborne Diseases

P

rithvi, Akash, Jal, Agni and Vayu – These are the five elements that we are made up of. Prithvi (Earth) and Akash (Sky) are beyond our control, Jal (Water) & Agni (Fire) are already taken care of in best possible ways. What about Vayu (AIR)? Air is the most important substance going into our body from outside. During the developing years (0 to 13 years) of a child, the impurities in AIR are ignored by most, causing the biggest damage to our health with several AIR BORNE DISEASES. The homes that we build today, in-spite of our perceived best architectural designs, we fail to comply with this basic need.

causing germs and irritants. “Several health authorities have recognized that certain types of air purifiers are beneficial in reducing the amount of Particulate Matter 2.5 in the room. During my studies of all Air Purification techniques, I have observed that the Sharp Air Purifier equipped with Plasmacluster Ion Technology is much superior in terms of performance, reliability and certifications. Proper ventilation and allowing direct

Sharp’s revolutionary air purifier enabled with its Plasma Cluster Ion Technology could be a real saviour. It creates forest fresh air by generating the same level of Positive & Negative Ions found in natural environments like forest, resorts, parks which in the process create Hydroxyl Radical (called Nature’s Detergent) thus killing harmful substances not only from the air but also from the surface and eliminates bad odour. Unlike other Air Purifiers, employing passive method that requires the air to pass through a set of filters to clean and recycle the air, Sharp comes with an Air Purification System as it incorporates an active method that reduces suffocation/ staleness by generating fresh air. Plasma cluster Ion Technology Mimics Nature by generating Positive and Negative Ions which are released into the air then reaches out to the surface and the corners of the room destroying infection 24 | November-December 2016 | Medical Device ASIA

sunlight in interior spaces are equally important steps towards improving air quality.” said Dr Rajarshi Bhattacharyya, National Head of The Times Foundation. Imagine a Petrol Engine running on a mixture of Petrol and Kerosene! If we breathe AIR and POLLUTANTS together, our Immune System is challenged, gets tired and the performance gets affected. We easily take Doctors’ assistance, who prescribes several expensive and harmful antibiotics to fight the common flu etc, if we rethink and use PREVENTION than CURE for airborne diseases, we might look forward to be a healthy nation. Breathing fresh air for at least 8 to 10 hours a day, will nourish the cardiovascular system and rest the Immune System thus giving the stamina and energy to fight diseases while in challenging environments.


OSH India 2016 echoes a positive wave in India’s Occupational Safety and Health industry • • •

India’s largest trade show for Occupational Safety & Health industry in Mumbai by UBM India A congregation of 160 renowned Indian and Global brands OSH India Safety Awards & Industry conference mark 5th edition

UBM India recently launched the 5th edition of the Occupational Safety & Health (OSH) India (10th - 11th November 2016) safety show at a newer and a bigger venue this year – the CIDCO Exhibition Centre, Vashi, Navi Mumbai. The show brought together internationally renowned exhibitors, consultants, business experts and key government officials under one common platform, to discuss global best practices and seek solutions to some of the most pressing challenges in the field of workplace safety and health.

T

he inaugural ceremony of OSH India, 2016 took place in the presence of Key Dignitaries, Shri Sudhakar Sambhaji Sonawane, Honourable Mayor, Navi Mumbai Municipal Corporation ( NMMC ); Shri Jayendra Motghare, Directorate of Industrial Safety and Health, Government of Maharashtra; Shri Ajay Pandit, Director (Technical), Office of the Textile Commissioner, Ministry of Textiles, Government of India; Smt. K. Hemalatha, Regional Executive Director, Western Region, Airports Authority of India (AAI), Govt of India; Sanjay Pathak, Director, Ordnance Factory Board, Regional Controllerate of Safety (WR) Khadki Pune, Ministry of Defence, Government of India and Mr. Yogesh Mudras, Managing Director, UBM India amidst an august industry gathering. The participation of leading exhibitors from across the industry reaffirmed the need and focus of OSH India as an industry event. These include, ‘Presenting Partner’ – Dickies (ID Overseas Pvt. Ltd.), ‘Occupational Safety & Health Partner’ - Euro Safety Footwear (India) Pvt. Ltd., ‘Platinum Partner - Udyogi International Pvt. Ltd. , ‘Gold Partner’- Venus Safety & Health and HAWS Corporation, ‘Silver Partner’- Prolite , Mallcom and Allen Cooper, ‘Knowledge partner’- Sure Safety, ‘Registration Partner’- Karam Industries , Work at height Partner – JLG and others such as Venus Safety & Health Pvt. Ltd, BATA India Limited, E.I.Dupont India Pvt Ltd, NEBOSH Ltd, and Tyco Safety Products (I) Pvt. Ltd. This year, the show has a presence of over 160 brands and will also see international participation from countries such as USA, UK, China, Germany, Srilanka, Norway, Japan and Malaysia. OSH India seeks to provide tangible solutions to a very pressing need in today’s workplace. The International Labour Organisation (ILO) and the World Health Organisation (WHO) have come up with different objectives for the subject of Occupational Safety Hazard such as the maintenance and promotion of workers’ health and working capacity; the improvement of working environment and work to become conducive to safety and health and the development of work organizations and working cultures in a direction which supports health and safety at work. These promote a positive social climate, smooth operation and enahnces productivity. 26 | November-December 2016 | Medical Device ASIA

Left to Right – Sanjay Pathak, Director, Ordnance Factory Board, Regional Controllerate of Safety (WR) Khadki Pune, Mr. Yogesh Mudras, Managing Director, UBM India, Sudhakar Sambhaji Sonawane, Honourable Mayor, Navi Mumbai Municipal Corporation ( NMMC), Shri Jayendra Motghare, Directorate of Industrial Safety and Health, Government of Maharashtra; Shri Ajay Pandit, Director (Technical), Office of the Textile Commissioner, Ministry of Textiles, Government of India; Smt. K. Hemalatha, Regional Executive Director, Western Region, Airports Authority of India (AAI), Govt of India; Ministry of Defence, Government of India at the inauguration of UBM India’s -- OSH India 2016 at CIDCO Exhibition Centre, Vashi, Navi Mumbai

Speaking at the inauguration of OSH India 2016, Mr. Yogesh Mudras, Managing Director, UBM India said, “In India, the problems surrounding occupational safety and health are aplenty including lack of awareness or coordination between various stakeholders, a growing informal economy, expansion of flexible forms of employment, expansion of labour migration, and new risks associated with the use of new technology. OSH India 2016, addresses this very need, and gives an opportunity to safety and health suppliers and service providers from across the world to showcase their innovations and knowledge amidst an industry landscape of a vastly untapped Indian market. It features a power-packed two day conference to drive occupational safety and health as a priority for companies which will

in turn translate into better health and productivity of employees, benefiting the organisation and economy at large.” The expo includes an Innovation Zone which is a platform for exhibitors to promote and showcase novel products that will benefit the occupational safety and the health industry. It also comprises a new feature this year – a two day ‘LIVE SEMINAR’, which is a safety awareness forum where safety experts from leading safety product manufacturers will discuss and demonstrate, over the course of the expo, the latest technologies, trends and topics related to safety at workplace. Some of the topics of the Live Seminar included -- Excavating Responsibility; How can you ensure safety at work place (practical case studies); protective coveralls :body protection (standards and


Key Dignitaries at the inauguration of OSH India 2016, India’s largest trade show for Occupational Safety & Health industry in Mumbai by UBM India.

practicability ); Explanation of Cosmos and products lineup / Q&A ; Principles on Fall Protection : focus engineering fall protection ; safety lighting : Atex, US standards and Indian standards and Ergonomics amongst others. This year’s power-packed conference shared and ideated on global best practice with delegates whilst the accompanying exhibition helped identify solutions to the most pressing challenges in the workplace safety and health domain. The key sessions and panel discussions at the conference were attended by industry experts from across the country and leading international organizations. The topics of discussion on Day 1 at the conference included: ‘OSH Challenges in India and the Way Ahead’, ‘Globalisation and The Changing World of Work’, An Integrated Approach to Worker Health’ a case study on ‘How Good leadership Can Drive Improvements in Process Safety’ and presentations on ‘Vision Zero: From Vision to Reality’ and ‘Behaviour Based Safety Management’. Day 2 will include a panel discussions on ‘Women and OSH’and ‘The Role of Industrial Hygiene in OSH. It will also include presentations on ‘Risk Assessment & Risk Governance’, ‘Fire and Electrical Hazard Prevention’, ‘Making Big Differences to Small Businesses’ and ‘ Health and Safety Risks in Construction’. Some of the distinguished speakers at the conference include Mr Vinayak Marathe, Senior Vice President, Reliance Industries Limited; Mr Suresh Tanwar, Chief Group Safety and Health, Tata Group; Mr Krishnanand Mavinkurve, Vice President & Head OSH, Adani Ports and Special Economic Zone Limited; Mr Sunil Bailwar, Vice President & Head Corporate Environment, Health & Safety - Hindalco Industries Limited; Mr Ashok Emani, Director & Head- ESG, IDFC Ltd.; Mr Badal Roy, General Manager, Head Safety Offshore Operations - Oil &

Natural Gas Corporation Ltd. (ONGC); Mr Pankaj Singh, General Manager - HSSE, India & South Asia, BP Castrol India; Mr JC Sekar, Co – Founder& CEO, AcuiZen Technologies Singapore Pte. Ltd.; Mr Stephen Philip Storey, Corporate EHS Head, Larsen & Toubro Limited India amongst others. OSH India 2016 is also witnessing the 4th edition of ‘OSH India Safety Awards’ open to Indian operating businesses, organizations, alliance and individuals in the public or private sector with a workplace health and safety initiative that complies with any one of the ‘Innovation’ or ‘Hero’ awards categories. Euro Safety Footwear (India) Pvt. Ltd. is the Presenting Partner for the Awards Night which will be a celebration of the coming together of the luminaries and fore-runners of the industry, marked by a night of glamour and entertainment. Industry validates OSH India 2016 as an industry platform and reiterates the objective of the annual expo in Mumbai by UBM India. Ms. Kavita Nigam, General ManagerPublicity & Promotion, Karam Industries said, “The OSH industry in India, though being a niche segment, has demonstrated rapid growth, primarily due to the entry

of multinationals. OSH India is the only trade fair to showcase the industry and provides us with a great platform to exhibit our new product offering and help build our brand further. With a focus on much needed Safety Training, KARAM is also launching unique products that would address safety for women at the workplace. These, along with our regular bouquet of products and services, would be exhibited at OSH India 2016, which will help us reach out to more customers. We are looking forward to OSH India 2016 and further build our brand, showcasing a wider product portfolio.” Mr Ankur Jain, Assistant Vice President, Bata India Ltd said, “The Occupation, Safety and Health industry is growing at the rate of 18% Y-o-Y, and we shall be witnessing a huge potential for the industry in the next 3-5 years. OSH India continues to be the only platform to represent the industry and we have become regular participants, since the past 3 years. We shall be launching our new range of colorful shoes in breathable material, which we shall be exhibiting at OSH India 2016, and look forward to close stakeholder interaction, including customers and traders.”

About UBM India UBM India is India’s leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences & seminars. UBM India hosts over 25 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia. For further details, please visit ubmindia.in. Medical Device ASIA | November-December 2016 | 27


Hon’ble PM Shri Narendra Modi visits Serum Institute

- Appreciates Adar Poonawalla Clean City Initiative Hon’ble Prime Minister Shri Narendra Modi visited Serum Institute of India Pvt Ltd, one of the world’s largest vaccine manufacturers and appreciated all efforts undertaken as part of ‘Adar Poonawalla Clean City Initiative’ for Swachh Bharat Mission. Some of the other dignitaries who graced the occasion were Hon’ble Chief Minister of Maharashtra Shri Devendra Fadnavis, Former Agriculture Minister Shri Sharad Pawar, Hon’ble Union Human Resource Development Minister Prakash Jawadekar and Hon’ble Governor of Maharashtra Shri Vidyasagar Rao. Mr Adar Poonawalla, CEO, Serum Institute of India, said, “We are honoured and priviledged to have hosted Hon’ble Prime Minister Shri Narendra Modi during his recent visit to our facility. The Hon’ble Prime Minister stressed that more companies should come forward to produce such vaccines so that poor children could be protected from diseases. We further briefed him on our Clean City Initiative. He was impressed and said that it was a good initiative under the Swachh Bharat Mission.” With an investment of Rs.100 crore as CSR funding from Serum Institute of India and Mr. Adar Poonawalla, this initiative promotes idea of clean city. The initiative has been successfully implemented through scientifically collecting and removing garbage from city streets. Serum Institute of India Pvt. Ltd. is the world’s largest vaccine manufacturer in number of doses manufactured and supplied to more than 140 countries. The vaccines include Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, Rubella, Meningitis A, Influenza and Polio vaccines. One of every two children born in the world receive a vaccine manufactured by Serum Institute. Serum Institute has established the most modern laboratories with high-tech machinery and computerized equipment for the production and testing of its life saving biologicals. Serum Institute’s commitment to global health is exemplified by significant investments in its infrastructure. The production facilities are continuously upgraded to ensure compliance with cGMP regulations and have been accredited by the World Health Organization, Geneva. 28 | November-December 2016 | Medical Device ASIA

Worrying traces of resistant bacteria in air Polluted city air has now been identified as a possible means of transmission for resistant bacteria. Researchers in Gothenburg have shown that air samples from Beijing contain DNA from genes that make bacteria resistant to the most powerful antibiotics we have.

Researchers found genetic material of resistant bacteria in air samples from Beijing; ©panthermedia.net/ bizoon

“This may be a more important means of transmission than previously thought,” says Joakim Larsson, a professor at Sahlgrenska Academy and director of the Centre for Antibiotic Resistance Research at the University of Gothenburg. Joakim Larsson and his colleagues have previously received attention for their research on waterborne release of antibiotics from pharmaceutical production in India, which was shown to trigger the development of resistant bacteria. In this new study, the researchers looked for genes that make bacteria resistant to antibiotics in a total of 864 samples of DNA collected from humans, animals, and different environments worldwide. “We studied only a small number of air samples, so to generalize, we need to examine the air from more places. But the air samples we did analyze showed a wide mix of different resistance genes. Of particular concern is that we found a series of genes that provide resistance to carbapenems, a group of last resort antibiotics taken for infections caused by bacteria that are often very difficult to treat,” says Larsson. The results do not show whether the sampled bacteria were actually alive in the air, which would make them a real threat. “It is reasonable to believe that there is a mixture of live and dead bacteria, based on experience from other studies of air,” says Larsson. The next step for the research is to find out if resistance spreads through air from European sewage treatment plants. This research will be carried out within the framework of a larger collaborative international project that has just been selected for funding by the Joint Programming Initiative on Antimicrobial Resistance (JPI-AMR), where the Swedish Research Council is providing the Gothenburg group’s financing. “We’re going to let treatment plant employees carry air samplers. We will also study their bacterial flora and flora of people who live very close and farther away, and see if there seems to be a connection to the treatment plants,” says Larsson. MEDICA-tradefair.com; Source: University of Gothenburg


Trivitron Healthcare in association with Sebia hosts

Symposium on HbA1c Measurement Trivitron Healthcare, the largest medical technology company of Indian origin, in association with Sebia hosted a Symposium on the updates of HbA1c measurement to highlight the relevance of the topic. Today, HbA1c is one of the latest diagnostic diabetes tools most nations have started adopting as a supplement to the existing blood glucose test. HbA1c is the glycated haemoglobin which develops when haemoglobin, a protein within red blood cells that carries oxygen throughout the body, joins with glucose in the blood, becoming ‘glycated’. HbA1c is measured primarily to identify the three-month average plasma glucose concentration. By measuring glycated haemoglobin (HbA1c), clinicians are able to get an overall picture of what the average blood sugar levels have been over a period of weeks/months. For people with diabetes, this is important as the higher the HbA1c, the greater the risk of developing diabetes-related complications. By measuring HbA1c, doctors get an overall picture of a patient’s blood glucose level over a period of weeks/months. In contrast to the regular fasting glucose test, which is an indication of one’s current glucose levels, HbA1c is more accurate and serves as an overall marker of one’s average levels over a longer time period. With as many as 50 million people suffering from type 2 diabetes (diabetes mellitus), India has more people living with the disease than any other nation in the world. If left unattended and untreated, diabetes can lead to severe health complications like heart disease, stroke, kidney disorders, retinopathy (cause of blindness) neuropathy or nerve damage leading to leg amputation and even blindness. As per the recent guidelines, HbA1c should be added as a means of diagnosing diabetes and identifying pre-diabetes. A number of techniques are used to measure hemoglobin A1c. The HbA1c result is calculated as a ratio to total hemoglobin by using a chromatogram, Immunoassay, Enzymatic, Capillary Electrophoresis & HPLC.

There are many factors that may interfere with HbA1c measurement like Uremia (carbamylated Hb), hemoglobin variants, drugs, opiates, bilirubin, triglyceride, alcohol. Interference of most common variants HbS, HbC, HbE, HbD has been a challenge to measure accurate value of HbA1c. Speaking on the occasion, Dr David Sacks, Expert in Clinical Chemistry said, “Considering the importance of diabetes as a major health issue globally, timely diagnosis and early initiation of appropriate treatment need to be viewed as a key priority. HbA1c is a proven method to make diagnosis more convenient, accurate and highspeed. Worldwide 1 in 2 people with diabetes is undiagnosed. It is the need of the hour to bring in a diagnostic tool like HbA1c, which is known for delivering accurate results in a short span of time, to be made more accessible and affordable to the common man.” Dr Garry John, Expert in Clinical Biochemistry and Immunology, added, “Ever since the American Diabetes Association recommended HbA1c as a diabetes diagnostic tool in its clinical practice recommendations (2010), many other progressive nations including European

countries followed suit. Countries like New Zealand and more recently, Malaysia have also adopted HbA1c to be an effective tool to reflect glucose levels. With the alarming incidence of diabetes and diabetes-related health complications in India, it would be beneficial the nation employs such efficient technologies for a better management of the disease.” Mr. Nitin Sawant, Senior Vice President, Trivitron Healthcare said, “Diabetes is the most talked about lifestyle disorder in India today. Declining rates of physical activity coupled with an increasing eating-out culture has led to an early onset of diabetes in many. However, with the right technology, we should be able to tackle the menace more effectively. Trivitron has always stood for cutting-edge technology which will enable cost-effective healthcare delivery solutions to the Indian masses. With appropriate awareness on HbA1c, we hope we can promote this globally-accepted technology as an efficient way to monitor diabetes accurately in India too.” This symposium is an effort to inform, educate and share experiences to understand the benefits on the importance of optimal Hba1c measurement and the way forward in India.

About Trivitron Healthcare: The genesis of Trivitron Healthcare Private Limited, dates back to 1997, when Dr. Velu, a first generation entrepreneur decided to build a company on the premise of delivering cost-effective medical technology solutions and services to the underserved. Today, Trivitron Healthcare, through successful inorganic synergies with local and global firms, has a revenue turnover of 750 crores, and is the largest medical technology company of Indian origin, with products exported to over 165 countries. Medical Device ASIA | November-December 2016 | 29


Blueair Launches ‘Clean Air For Everyone’ Program In The Presence Of Union Minister Mr. Nitin Gadkari Thousands Of Children To Benefit Through Immediate Donation Of 200 Blueair Air Purifiers to Delhi Schools capital. As part of a longer-term project, Blueair says it looks forward to working closely with the government to help spread the initiative and increase awareness among younger people about ways to combat air pollution and protect the environment.

Union Tranport Minister Nitin Gadkari and Bengt Rittri, founder & CEO of Blueair

Blueair, a world leader in indoor air cleaning technologies, today committed to positively impact the lives of schoolchildren in India through a ‘Clean Air for Everyone’ program. Blueair’s nationwide program gets underway with the immediate donation of 200 Blueair air purifiers that will benefit the lives of 10,000 students in schools across the capital. Going forward, Blueair said it is looking to make the program sustainable over the long term by encouraging like-minded corporations interested in improving the health of school children to partner in creating joint air pollution battling programs. Designed to give school children a pollution-free environment in classrooms, the Blueair program was launched in Delhi in the presence of Mr. Nitin Gadkari, Union Minister for Road Transport and Highways. “Clean air is a basic right of every child, and a society’s concern towards its future generations is displayed in how it cares for those who are most susceptible and vulnerable. Sadly, air pollution is such an enormous problem that millions of children across India are breathing air that threatens their development, health and safety,” said Bengt Rittri, Blueair’s founder and CEO. He added: “We are failing those children if we do not help them. On the back of the severe pollution seen during Diwali in Delhi, Blueair is launching this initiative by immediately donating air purifiers to Delhi schools as a first step.” Children are particularly at risk from polluted air. A 2015 Blueair report that studied the lung capacity of children living in four major cities, including Delhi, found that 40% of the children in the national capital were suffering ‘poor’ or ‘bad’ lung capacity. Today’s donation will benefit many thousands of school children by putting Blueair’s health-protecting air purifiers in classrooms across the 30 | November-December 2016 | Medical Device ASIA

“Fighting pollution is a partnership between people and governments, and should be jointly pursued. However, we must provide the most vulnerable immediate relief by at least protecting them from contaminated indoor air, which can be many times worse than that outside. For us, it is a natural step to start with classrooms,” said Girish Bapat, Blueair Director South and West Asia. “We are always deeply concerned about the health of our youngest, and we appreciate the start that Blueair has made with this donation drive. We plan to use the air purifiers in the classes of the youngest students, and create a safe air zone in classrooms,” said Mr. Liris Thomas, Trustee, New Generation Trust, which runs schools called Rafa Homes for underprivileged and HIV affected children aged between 5 to 13. “I started Blueair 20 years ago because I wanted my son and daughter to benefit from the same clean air where we lived in the city as they did at my summer house in the Stockholm archipelago. I am deeply pained when I see suffering being inflicted on innocent children by air pollution. For over 20 years we have been driven by the goal to deliver the world’s best indoor air purifiers. Now, with the ‘Clean

Air For Everyone’ program, we are making a meaningful difference to children’s lives by providing them air as clean as nature intended,” said Mr. Rittri. BACKGROUND INFORMATION o In its ‘Clean the air for children’ report, UNICEF said air pollutants don’t only harm children’s developing lungs – they can actually cross the blood-brain barrier and permanently damage their developing brains. UNICEF said outdoor and indoor air pollution are together directly linked with pneumonia and other respiratory diseases that account for almost one in 10 under-five deaths, making air pollution one of the leading dangers to children’s health. • A new study in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine found childhood asthma was 20 percent higher among people exposed to London’s Great Smog event during their first year of life compared to those living outside the city. • Schools in Delhi receiving the first donation of Blueair air purifiers include The Blind Relief Association, New Generation Trust, Guru Harkrishan Public School, Choghlae Public School and Nutan Marathi School. About Blueair Blueair is sold in over 60 countries around the world and delivers home and office users more clean indoor air for enhanced user health and wellbeing faster than any competing air purifier. For more information, visit http://www. blueair.com


MEDICA and COMPAMED 2016 provide a powerful stimulus for the international medical technology industry Top decision makers negotiate top partnerships - business relationships change in a fundamental manner

Once again, the world’s biggest medical trade fair MEDICA and the leading international supplier trade fair COMPAMED, which take place in Düsseldorf, have provided a powerful stimulus for the international medical technology industry. For each of the four days of the fair, from 14 to 17 November 2016, specialists from all sectors of the health industry ensured that the daily intake of visitors was consistently high (in total: 127,800 visitors) in the trade fair’s 19 halls, which were fully booked by exhibitors. In addition to exciting topics which have been “electrifying” everyone in the sector, no matter where they are from (the keyword here is digitisation), it has been noticeable that, above all, the business relationships between providers and clients have fundamentally changed. Pure product orientation is a thing of the past. Medical technology companies negotiate systems partnerships with hospitals and medical facilities that are designed for the long term within the scope of comprehensive process optimisation. “Now more than ever, medical technology companies are focusing on top decision makers on the demand side, particularly those from hospital

management and purchasing bodies. MEDICA fully lives up to this trend. Over 80 percent of our trade visitors have significant decision making power”, summarises Joachim Schäfer, Managing Director of Messe Düsseldorf. Other factors could come into play for the MEDICA 2016 exhibitors (numbering over 5,000, the largest number of exhibitors to date) with respect to export business, which is experiencing a particularly high growth rate. Joachim Schäfer explains: “The MEDICA, as a space for global business and creating contacts in all important

markets, is simply unmissable. Our trade visitors came from over 135 different countries, with Asian emerging countries being particularly well represented once more. Around 60 percent were international visitors, which is a new high.” The significance of this high amount of international participants and businesses at MEDICA is confirmed in the current reports from the trade associations on the business development of their member companies, submitted on the occasion of the world’s leading trade fair. According to

Medical Device ASIA | November-December 2016 | 31


these reports, the innovation-driven German medical technology industry is growing above all via export. “Although in a traditional market, uncertainties like Brexit or the situation in Turkey can halt growth, many emerging countries offer further great potential to combat this because of the massive investments in their local healthcare systems”, explains Marcus Kuhlmann, Leader of the SPECTARIS German Medical Technology Industry Association.

can be transferred directly into tubes for magnetic resonance imaging (MRI) in this incubator, thereby avoiding wasting time transferring them into another bed. LMT worked closely with MRI manufacturers such as Philips and Toshiba during product development.

Cooperation to produce optimal solutions

Richard Wolf GmbH provides a particularly strong example of how a provider for individual specialist products can transform itself into a comprehensive solution system provider. The company, originally known for its endoscope systems, exhibited, among other items, a new ENT diagnostic navigation system in Düsseldorf and now also offers solutions for operating theatre integration. This integration comprises the centralized control of different devices and equipment (from different manufacturers) in operating theatres. Richard Wolf GmbH underlines this change in

Medical technology manufacturers are entering into cooperative partnerships in order to be able to offer their clients, in both the outpatient and inpatient care sectors, optimal solutions. For many businesses designated as smaller or medium sized, MEDICA offers by far the best opportunities to meet with specialist traders from all over the world and thereby improve their market presence. “MEDICA gives us an excellent platform to exchange with an international trade audience and find new distributors every year. We got to know a large number of our longstanding sales and distribution partners here”, says Nina Friedrich, Head of Marketing for LMT Medical Systems, highlighting the importance of participating in the fair. LMT presented a special incubator at MEDICA 2016. Premature babies 32 | November-December 2016 | Medical Device ASIA

position with a new approach to exhibiting at MEDICA. “In terms of strategy, we are now concentrating on selling entire systems as opposed to individual instruments. Consequently, we have also changed our distribution structure – we are pulling away from general traders and converting to distributors with expertise in specialist fields. We use MEDICA in the traditional manner to find new contacts within the market”, says Jürgen Steinbeck, CEO of the Richard Wolf Group, describing the targeted process. This is similar to SECA’s approach. SECA has been exhibiting at MEDICA right from the beginning. Previously a specialist in scales, SECA has vastly broadened its range of expertise: “If we compare our portfolio today with the first time that we came to MEDICA, we can clearly see that we are progressively developing into a hardware and software provider. We no longer


manufacture scales alone, but also measuring stations that communicate with each other and service systems to make everyday medical practice easier.”

Connected and mobile – digitisation, the word on everyone’s lips One subject that currently affects almost all exhibitors and visitors equally, and which was also on everyone’s lips in the conference halls, is the rapidly advancing digitisation of the healthcare industry, which aims to connect the actors in the treatment process. Hans-Peter Bursig, Chairman of the ZVEI Electromedical Technology area of competence, sees a fundamental requirement for personalised patient-centred care within this and simultaneously the optimal response to the demographic change and the demands it places upon the healthcare system: “As patients use digital care solutions such as telemonitoring and medical apps, patient-centred healthcare can become a continual process. Now, the quality of treatment for chronic illnesses, which increase in onset with age, is improving vastly.” The forums integrated into MEDICA offer a range of solutions that fit this theme which many of the visitors have used. At the MEDICA HEALTH IT FORUM (Hall 15), some of the topics discussed included factors for success in the implementation of medical apps

and concrete examples of digital healthcare aids which are recommended by experts involved, such as doctors. MEDICA CONNECTED HEALTHCARE FORUM took current developments and new products in the area of wearables for medical use as its main theme. The MEDICA App COMPETITION constituted one of the highlights here. 15 development teams from all over the world competed in a challenge to create the “Best Medical Mobile Solution”. The victor was “Up Right”, a combination of an app and a weareable from a development team from Israel. This application helps to optimize posture and stimulates movement. It vibrates on the user’s back as soon as they sit in a slouched position.

Diverse conference programme proves to be an expert magnet

The essential market trends were also expanded upon with the content of MEDICA’s accompanying conference and convention programme, which were oriented to target groups. “Joints and Joint Replacement” was this year’s main theme at the MEDICA PHYSIO CONFERENCE, to give one example. In highly attended lectures, the extent to which physiotherapy, sports or spiral dynamic movement and therapy offer effective therapeutic strategies was explored for those who wish to optimise the condition of their joints, including artificial joints. Other conferences which should be mentioned include the international military and disaster medical conference DiMiMED as well as the MEDICA MEDICINE SPORTS + CONFERENCE. At this conference, specifically created for the specialists from the sport and preventative medicine sectors, general possibilities for increasing physical and mental

Medical Device ASIA | November-December 2016 | 33


performance (exemplified in training programmes for Luftwaffe pilots) were discussed as well as effective implementation of wearables for monitoring vital signs and injury prevention, to give two examples. The 39th German Hospital Conference offered over 2,100 participants a multitude of health politics and practice-oriented sessions as part of this year’s general theme of “Shaping the Future”, serving as a significant communication platform for clinical management. The diverse content ranged from quality requirements and hospital planning and clinical IT to central challenges for investment financing. The most famous visitor was the German Federal Minister of Health, Hermann Gröhe, who caught up on selected innovations for modern and connected patient-centred care on a tour of the exhibition after the opening of MEDICA 2016 and the German Hospital Conference.

Suppliers - the best partners for product development In connection with MEDICA, COMPAMED was held for the 25th time. COMPAMED is a leading event for the supplier market in medical technology manufacturing. In both halls (8a and 8b) the 19,000 visitors could find information on innovations and 34 | November-December 2016 | Medical Device ASIA

relevant trends in product development from the 774 exhibitors from 37 countries, as well as in two expert forums. In addition to the presentations on everything from components and materials to comprehensive service provision for the medical technology industry, COMPAMED has become a hotspot for complex high-tech solutions for procurement, production officers, developers and also for research. This year, compact and mobile electronics and the benefits and challenges of 3D printing were the main focus, with aspects of the increasing digitisation of patient centred healthcare also being focused on yesterday, as was the case in all the other conference halls.

Dates of the next MEDICA + COMPAMED in Düsseldorf: 13 - 16 November 2017


Exercise in middle age may safeguard cognition in old age

V

obesity, and binge drinking, the association remained statistically independent, the researchers found.

Vigorous exercise in middle age is associated with less cognitive impairment in old age, a new study found.

“This suggests that the beneficial influence of physical activity on the brain and cognition is not solely based on decreasing vascular risk factors,” said lead author Paula IsoMarkku, MD, of the Department of Clinical Physiology and Nuclear Medicine at the University of Helsinki, in Helsinki, Finland.

Exercise offers better benefits for its believers Physical activity doesn't improve cognition in older adults, but it may maintain it Even after adjusting for common risk factors such as midlife hypertension, smoking, education level, gender,

For this study, participants in the Finnish Twin Cohort replied to questionnaires about physical activity in 1975 and 1981 (mean age in 1981: 49 years). Between 1999 and 2015, after an average follow-up of 25 years (mean age: 74.2),

igorous physical activity during midlife was associated with a 50% lower risk of cognitive impairment in old age, according to a long-term study of 3,050 twins in the Finnish Twin Cohort, published online September 2, 2016 in the Journal of Alzheimer's Disease.

researchers evaluated the subjects’ cognition through validated telephone interviews. The researchers categorized participants as cognitively impaired, suffering mild cognitive impairment, or cognitively healthy. “Few long-term, high-quality, followup studies on physical activity and cognition have been published, and it has remained unclear what type and amount of exercise is needed to safeguard cognition,” Dr. IsoMarkku noted. This long-term study provided some answers. “Overall, the study shows that moderately vigorous physical activity, meaning more strenuous than walking, is associated with better cognition after an average of

25 years,” explained Urho Kujala, MD, PhD, Professor of Sports and Exercise Medicine at the University of Jyväskylä, Finland. “This finding is in accordance with earlier animal model studies, which have shown that physical activity increases the amount of growth factors in the brain and improves synaptic plasticity.”

However, the researchers found that the volume of physical activity did not reflect any further cognitive improvement in a dose-dependent manner. In other words, more exercise didn’t necessarily lead to better brain power later on.

Medical Device ASIA | November-December 2016 | 35


Medical Device Reporting (MDR) What is Medical Device Reporting (MDR)?

User Facilities and MDR

History of MDR Regulation

Update on FDAMA

Although manufacturers and importers of medical devices have been required since 1984 to report to FDA all device-related deaths, serious injuries, and certain malfunctions, numerous reports have shown there is widespread underreporting.

What is Medical Device Reporting (MDR)? Medical Device Reporting (MDR) is the mechanism for the Food and Drug Administration to receive significant medical device adverse events from manufacturers, importers and user facilities, so they can be detected and corrected quickly. If you are a consumer or health professional you should use the nearby link to the MedWatch program for reporting significant adverse events or product problems with medical products. User Facilities and MDR User Facilities (e.g., hospitals, nursing homes) are required to report suspected medical device related deaths to both the FDA and the manufacturers. User facilities report medical device related serious injuries only to the manufacturer. If the medical device manufacturer is unknown,

the serious injury is reported by the facility to FDA. Health professionals within a user-facility should familiarize themselves with their institution procedures for reporting adverse events to the FDA. There is a guidance for user facilities, "Medical Device Reporting for User Facilities". See its nearby link. Note: Please do not send the actual device to FDA as stated in Block D9 of the MEDWATCH 3500A form. In Block D9 indicate that you are keeping the device or returning it to the manufacturer. History of MDR Regulation Legislation requiring device user facility reporting was enacted by Congress to increase the amount of information the Food and Drug Administration (FDA) and device manufacturers receive about problems with medical devices.

36 | November-December 2016 | Medical Device ASIA

A 1986 General Accounting Office (GAO) study showed that less than one percent of device problems occurring in hospitals are reported to FDA, and the more serious the problem with a device, the less likely it was to be reported. A GAO followup study in 1989 concluded that despite full implementation of the Medical Device Reporting (MDR) regulation, serious shortcomings still existed. Under the Safe Medical Devices Act of 1990 (SMDA), device user facilities must report devicerelated deaths to the FDA and the manufacturer, if known. Device user facilities must also report device-related serious injuries to the manufacturer, or to the FDA if the manufacturer is not known. In addition, SMDA also required that device user facilities submit to FDA, on a semiannual basis, a summary of all reports submitted during that time period. The device user facility reporting section of SMDA became effective on November 28, 1991. To implement SMDA, FDA published a tentative final rule in the Federal Register on November 26, 1991, and invited comments on the regulation. Over 300 comments were received by FDA. Then, on June

16, 1992, the President signed into law the Medical Devices Amendments of 1992 (Public Law 102-300; the Amendments of 1992), amending certain provisions (section 519 of the Food, Drug, and Cosmetic Act) relating to reporting of adverse events. The primary impact of the 1992 Amendments on device user facility reporting was to clarify certain terms and to establish a single reporting standard for device user facilities, manufacturers, importers, and distributors. A final rule published in the Federal Register on December 11, 1995, addresses the comments received by the FDA and the changes mandated by the Amendments of 1992. Update on FDAMA The Food and Drug Administration Modernization Act (FDAMA) was signed on 11/21/97 and became effective on 2/19/98. There were four changes that affected MDR: Manufacturers and distributors/ importers do not need to submit annual certification. Domestic distributors are no longer required to file MDR reports, but must continue to maintain complaint files. [Importers (initial distributors for devices manufactured overseas and imported into the USA) must continue to file MDR reports.] User facilities must now file an annual report instead of semiannual reports to summarize their adverse event reports. Sentinel reporting by user facilities was proposed.


Miele: New large steam sterilisers add a ‘fourth dimension to reprocessing’

A further highlight awaiting visitors to the 340 m² large Miele booth will be a virtual tour of a fully furnished and equipped reprocessing unit for medical products. Using virtual reality glasses and joysticks, guests are invited to wander through the various reprocessing rooms and to discover for themselves the special features of Miele products. This virtual excursion also passes through the inside of a mobile CSSD. This modular and prefab unit is available from Miele Professional in the event that a hospital has to close its own facilities temporarily, for example for renovation work.

A safe titre count reduction in large steam sterilisers from Miele Professional is guaranteed by a new sensor which monitors the complete penetration of loads with saturated steam; ©Miele

Visitors to Miele Professional’s stand at Medica experienced a new dimension in medical technology: New features for large steam sterilisers due to be launched in May 2017 as well as a virtual tour of a fully equipped reprocessing unit for medical products at their Booth in Hall 12, Stand F 18. Alongside temperature, pressure and holding time, the complete penetration of loads with saturated steam is essential to the successful deactivation of bacteria in any sterilisation process. ‘We call it the fourth dimension of reprocessing’, says Chief Product Manager for Medical Technology with Miele Professional, Michael Sedlag, as he explains the origins of Miele’s tradeshow motto. Miele is presenting a process on its new sterilisers which monitors the quality of steam and steam penetration more effectively than for instance indicators. This is the preserve of an innovative Miele sensor which measures the penetration of the system with saturated steam. The full and reliable deactivation of bacteria is only possible through the presence of saturated steam at all points. Moist steam or superheated steam on the other hand is less effective and indeed involves risks, particularly with respect to complex loads. With Miele’s innovative sensor, the necessary level of penetration can be precisely monitored. The sensor operates on the basis of light, giving users the peace of mind of knowing that safe sterilisation has been achieved. Two further optional new features to be presented by Miele Professional at Medica 2016, also serving the objective of ensuring safe sterilisation, are a sensor to detect non-condensable gases in a steriliser’s steam supply and an Air Detector which identifies possible air leakages. Another market

first is the automatic descaling function on the vacuum pump on large steam sterilisers. This can considerably prolong a pump’s service life and reduce the need for maintenance in the event that the required quality of cooling water cannot be provided on site.

Miele will also be presenting new products for surgeries as part of System4Med, including a load carrier for undercounter washerdisinfectors with a large capacity of up to 8 DIN mesh trays for surgical instruments. A new system ensuring the thorough but gentle reprocessing of the instruments used in eye surgery and permitting the cleaning of complete instrument cartridges will also be presented.

Company profile Miele is the world’s leading manufacturer of premium domestic appliances including cooking, baking and steam-cooking appliances, refrigeration products, coffee makers, dishwashers and laundry and floor care products. This line-up is augmented by dishwashers, washer-extractors and tumble dryers for commercial use as well as washer-disinfectors and sterilisers for use in medical and laboratory applications (Miele Professional). The Miele company, founded in 1899, has 8 production plants in Germany as well as one plant each in Austria, the Czech Republic, China and Romania. 2015/16 turnover amounted to approximately EUR 3.71 billion with sales outside Germany accounting for around 70 percent. Miele is represented with its own sales subsidiaries and via importers in almost 100 countries. Throughout the world, the company, now in fourth-generation ownership, employs a workforce of 18,400, thereof 10,300 in Germany. The company’s headquarters are located in Gütersloh in Germany’s Westphalia region. Medical Device ASIA | November-December 2016 | 37


CSA: The new Medical Device Regulation – A substantial impact on medical device manufacturers

on the same principles as the directives, there are many areas that have been strengthened: more rigorous designation and oversight of Notified Bodies, clearer incident reporting and coordination between national surveillance authorities, expanded traceability, UDI and implant cards and expanded requirements for clinical evidence.

The European Parliament called for a revision to the existing medical directives and associated legal framework to guarantee the safety of medical technology. Therefore, the EU Medical Devices Directive (MDD) and the Active Implantable Medical Device Directive (AIMDD)) will be replaced by a new Medical Device Regulation (MDR). This has significant impact on some classifications, conformity assessment, safety & performance requirements and clinical evidence. Learn more about the new Regulation at MEDICA 2016 at the booth of BSI and CSA Group (Hall 10, Stand E03).Together with the new In Vitro Diagnostic Regulations (IVDR), which will replace the In Vitro Diagnostic Directive (IVDD), the new (MDR) will entail significant changes for every medical device manufacturer who already places products on the market in the EU or who wants to bring their devices to the European Market.

Regaining public trust – New labeling, more transparency, stricter requirements The PIP breast implants fraud case not only showed a lack of transparency, but it led to a decrease of public trust in the system and CE-marking. Thus, with the new MDR, an extended database on medical devices providing more information on the quality and safety of devices on the market will be available. Another improvement is the introduction of Unique Device Identification (UDI) codes to enhance post-market safety, to reduce medical errors and to fight against counterfeiting. Additionally, manufacturers of implantable devices are to provide an implant card, allowing the identification of the implant and giving information about it. Also, several devices that were beforehand classified as IIb are classified as class III now. This includes, among others, most implants and certain devices incorporating nanomaterial. This means that a technical documentation review and product certificates are necessary. The requirements regarding clinical evidence have been taken from existing standards (ISO 14155) and guidance (MedDev 2.7.1) and included in the Regulation. The MDR requirements in the post-market phase for clinical follow-up are taken from MedDev 2.12-2. Additionally the regulation applies the general rule that class III and implantable devices should be evaluated on the basis of clinical investigation data. 38 | November-December 2016 | Medical Device ASIA

The activities of Notified Bodies The MDR changes the oversight of Notified Bodies (NB). Whereas with the MDD control and monitoring was largely on a national approach, with the MDR control is down to member states and the Commission. It also has an effect on the NB’s Sown quality systems. The MDD had one page of requirements for Notified Bodies. Regulation 920/2013 increased these significantly. Annex VI of the proposed MDR has 33 pages of detailed requirements for Notified Bodies. Requirements for unannounced audits described in Recommendation 473/2013 have also been included in the regulations. Annex VI includes requirements for physical, laboratory or other tests have to be carried out by NBs in the context of sample checks, assessment of the technical documentation and type examination. These tests will have to be completed by appropriate laboratories. Testing may be to harmonized standards or to common specifications in the future. The impact on medical device manufacturers, Notified Bodies and other stakeholders The new regulations are based

“From the point of view of a test laboratory, the MDR does not require new evidence for the product standards”, emphasizes Stefan Hofmann – Team Lead Medical and Head of Laboratory at CSA Group Europe GmbH. “And although the harmonized standards are known from the MDD, the ‘common specification’ still is a new conception, also for the test laboratories, we do not know if the Commission will harmonise the standards against the Regulations. The alliance between CSA Group, a world leading medical device testing and certification organization and BSI, one of the leading Notified Bodies in Europe, brings together an unrivaled mix of expertise, enabling manufacturers to create and bring their medical devices to patients and healthcare professionals all over the world, fast and predictably. CSA Group and BSI understand that speed and certainty about project deadlines is paramount when accessing global markets. They have therefore have built a global strategic alliance to provide a one-stop service that guides electro-medical device manufacturers through the key stages of market access: Product Testing according to IEC 60601; CE-Marking incl. Technical File Review; Quality Management System Assessment according to ISO 13485.


Connect with Northern Ireland’s worldclass life and health sciences sector Fourteen highly innovative and experienced Northern Ireland companies with proven expertise in areas ranging from diagnostics testing and reagent manufacture to medical instruments and ophthalmology recently showcased at MEDICA. The world-class products and depth of knowledge represented on the stand made it an unmissable stop along the MEDICA 2016 trail for those seeking trusted, capable suppliers, medtech solutions or expert and visionary collaborators. Northern Ireland companies showcased at MEDICA with innovative products such as Eyepeace from Cathedral Eye Clinic – a first-to-market eyelid massager designed to prevent and treat meibomian gland disease, posterior blepharitis and dry eye disease. A range of high quality medical products will be promoted including Ciga Healthcare’s award-winning rapid diagnostic tests, Biopanda’s test reagents and Safety First Sales’ X-Ray protection garments. Armstrong Medical showcased its respiratory disposables and Limpeeze its novel first-aid kit for feet. Northern Ireland’s expertise in connected health will be evident in the range of patient monitoring systems on show from G-Care, Intelesens and TriMedika, including non-invasive vital signs monitoring devices. The region also has an impressive reputation in electronics and IT and a number of companies will be exhibiting their expertise in this area. These include Clinishare, which will demonstrate its advanced software that connects patients, healthcare workers and labs, and Exploristics, which offers data management, programming and statistical support for research studies.

Yelo promoted its state-of-the-art automated laser testing equipment and Elite Electronic Systems its range of electronic support solutions. These companies give a flavour of the innovation and cutting-edge technology that exist in Northern Ireland’s thriving life and health sciences sector, which is enjoying annual growth rates of 10%. Northern Ireland has a history of pioneering research and development in the sector, stretching back to the development of the world’s first portable defibrillator, and this continues today across its businesses, academic institutions and research organisations. The region is home to highranking, internationally recognised universities, Queen’s University, Belfast and Ulster University which are carrying out world-leading research across a range of medical conditions and biomedical sciences.

Northern Ireland’s researchers are at the forefront of research and development and have particular expertise in precision medicine and connected health. The country’s integrated health and social services offers a unified approach to patient engagement and lends itself to the adoption and scaling up of new clinical interventions. There is also openness to, and appreciation of, the potential offered by collaboration which is supported by Invest Northern Ireland, Northern Ireland’s main economic development agency. This has led to close links between industry and researchers and ongoing healthy investment in the sector. On the Northern Ireland stand you’ll find out more about Northern Ireland’s life and health sciences sector, as well as companies that are keen to trade, keen to collaborate and keen to go the extra mile to meet your specific needs.

IMMS harnesses for point-of-care diagnostics

Test setup with live demonstration for personalized diagnostics of cancer during MEDICA At the MEDICA 2016 IMMS presented its first approaches for the personalized diagnostics of cancer using a prototype device. It was developed in the threeyear research project INSPECT which started in June 2016. IMMS focusses on the integration of various sensor principles of different biological and chemical measurands into one integrated electronic device for extensive and precise diagnostics. The work is based on cost-efficient standard semiconductor manufacturing processes (CMOS) which IMMS also uses for these new diagnostic approaches. IMMS adapts its systems to application-specific needs by means of

particular functionalisation of surfaces and the use of biocompatible material. These solutions should pave the way for fast, reliable, costefficient and automated in-vitro diagnostics, such as early recognition of cancer. In the INSPECT research project IMMS is developing systems for the early recognition of breast, cervical, prostate and lung cancers using semiconductor chips as well as immunological and cell-based biotechnological methods. IMMS is working on an interdisciplinary interface between biology and microelectronics for signal processing. In addition, further concepts for microelectronic-based point-ofcare diagnostics and for personalized cancer immunotherapies are being investigated. IMMS is currently testing the first prototypes of the miniaturized diagnostic devices. The research partners iba Institut für Bioprozess- und Analysenmesstechnik e.V. Heiligenstadt, Senova Gesellschaft für Biowissenschaft und Technik mbH Weimar, CDA GmbH Suhl and X-FAB Semiconductor Foundries AG Erfurt are contributing to the novel solutions. IMMS is coordinating the consortium. Medical Device ASIA | November-December 2016 | 39


GPC: Orthopaedic implants -

Quality and Costs Innovation in Orthopaedic Implants has proved to be a boon for numerous lives, not only the elderly but the accident victims also. It is inarguably the most important medical innovation of our times. These implants improve the quality of life of a large number of people. Orthopaedic Implant Technology continues to evolve and improve. But higher costs come together with these improvements, too. Recent studies indicate that the costs of Orthopaedic Implants continue to rise over 13 percent annually. On the other hand, hospital profits and physician reimbursements continue to decline. Cost-cutting strategies have been a major concern for hospitals without compromising the quality of the products. Orthopaedic implants designed and manufactured by GPC Medical Limited, India, are at par with the International Quality Standards. We are the only Indian company to have a widest range of Orthopaedic implants that are US FDA 510 (K) approved. Even then high prices are kept at bay. Our products have shown similar, or even better, clinical results not withstanding the lower prices. This fact is proven by the increasing demand of our Implants as well as the growing number of satisfied clients! Thus we at GPC provide a grand opportunity to hospitals worldwide to save millions of dollars on quality Orthopedic implants and instruments. About GPC GPC are leading manufacturers and exporters of an extensive range of Hospital Equipment, Furniture, Anaesthesia Products, Labware & many more. Our company is ISO 9001:2000 and ISO 13485:2003 certified and WHO-GMP compliant. There is hardly a country where the GPC products have not found their way. GPC regularly wins some major projects in different countries against MOH/MOD/UN tenders, to name only a few. 40 | November-December 2016 | Medical Device ASIA

Taiwan Excellence: Taiwan’s Medical Device Industry Taiwan holds a competitive advantage in several industries that the medical device industry relies upon, including electronics, ICT (Information and Communication Technologies), precision machinery and fasteners. As a result, Taiwan is able to develop and manufacture high quality medical devices with costs far lower than that of US and Europe. In addition, government support in forms of funding and favorable regulations not only stimulates but also accelerates innovation and new technologies in Taiwan’s medical device industry. As a result, the focus of Taiwan’s medical device industry has shifted from production only to R&D and innovation. A glimpse of the Taiwanese companies, who were present at MEDICA: HIWIN is ranked 37th on Forbes’ World’s Most Innovative Company list. Utilizing expertise in precise motion control, HIWIN is going to talk about robotic rehab therapy and ubiquitous healthcare service. AmCad has invented the Computer Assisted Detection Software device to detect the risks of Obstructive Sleep Apnea. Standard methods require the patients to stay overnight at the hospital and sleep while wearing an uncomfortable mask. This device allows the physicians to evaluate the risks of Obstructive Sleep Apnea within 15 minutes while the patient is awake. EverBio is going to present the world’s first fully automated Tissue

MicroArrayer (TMA) with the highest throughput of tissue blocks. This invention is a huge contribution to the development of precision medicine and personalized medicine. Shoprider is going to present the ROVI Power Wheelchair. Corners,

high curbs, uneven road surface and steep slopes will no longer limit the mobility. Adronic has developed a unique light source system and customized camera for its medical endoscope to increase sensitivity and accuracy during examination.

Visitors took a closer look at the Taiwan Excellence award winning products during MEDICA. The winners were selected by international judges based on the five key indicators: R&D, Design, Quality, Marketing and the fact they’re Made in Taiwan.

Export statistics Unaffected by the overall slowdown of the economy, the export of Taiwan’s medical devices has been growing steadily since 2005. During 2011 – 2015, export of medical devices has increased by a CAGR (Compound Annual Growth Rate) of 8.6%, reaching $1.82 billion USD by the end of 2015. Due to the increasing demand from a rapidly aging global population, the market will continue to expand in the coming decade.

Taiwan’s export of medical devices


Sony’ smart end-to-end medical workflow innovations at MEDICA 2016

New workflow solutions for the Integrated OR support more efficient diagnosis, surgery and post-operative care in today’s networked hospital environment Sony showcased its latest end-to-end solutions that support more efficient diagnosis, surgery and post-operative care at the recently held MEDICA, in Germany. Visitors were able to experience how Sony’s innovations enable more efficient capture, sharing and display of high-quality video and still images in today’s networked hospital environment. Smart Digital Operating Room workflow with NUCLeUS™ Bringing Sony’s end-to-end range of medical solutions to life, the MEDICA stand will include two interconnected Surgical Workflow areas. Showcasing a new generation of smart workflow solutions for the Integrated Operating Room, we will demonstrate how clinicians can capture, share and display images recorded during surgery across the hospital network in Full HD and 4K. The Operating Room (OR) setup will be powered by NUCLeUS™, Sony’s new Video-over-IP platform, which delivers full IP communication. Enabled by the new NU-IP40S or NU-IP40D IP converters, the platform improves the surgical workflow through OR planning integration, pre-sets per surgeon and instant collaboration. Outside the OR, staff can view live surgical content and have access to an online video-on-demand platform so they can view the content they need, whenever they need it. “By combining our vast knowledge and experience of imaging technology with the streamlined workflows offered by the recent acquisition of eSaturnus’ solutions, we’re revolutionising modern surgical workflows and further developing smart clinical Video over IP solutions for inside and outside operating rooms,” said Rolf Messmer, Strategic Marketing Manager AV/IT Healthcare Solutions at Sony Professional Solutions Europe. “Sony continues to develop and deliver state-of-the-art medical solutions and services to customers, bringing a smart and flexible workflow solution to the digitally integrated OR. It enables not only the processing, control and distribution of multiple image sources, but allows clinical staff to view these images with outstanding visual quality.”

Enhanced visualisation for better decisions As part of Sony’s commitment to deliver enhanced visualisation, it will be showcasing its latest surgical monitors at the show. The new LMDX550MT (55”) and LMD-X310MT (31”) surgical monitors combine 4K and 3D for the first time, delivering high brightness, enhanced resolution and increased depth of field to help surgeons make more informed decisions and improve training. They’ll be joined by the new LMD-2735MD (27”)

and LMD-2435MD (24”). Full HD monitors that offer superior image quality at an accessible price, designed for use with endoscopic camera systems during minimally invasive surgical procedures. Delivering compelling images on any scale, Sony’s revolutionary CLEDIS™ Display solution will also be on show. The large-scale presentation solution combines multiple energy-efficient display modules to create flexible, supersized displays for use in operating rooms, training suites or reception areas. The award-winning CLEDIS technology delivers impressively life-like images with a wide colour range, vivid brightness and contrast with a virtually 180 degree viewing angle. The following new medical solutions were also launched during MEDICA:

Easy recording, quick sharing Also was on display for the first time in Europe, the HVO-3300MT is Sony’s latest 3D/2D HD video recorder. Smaller and lighter than the previous-generation HVO1000MD and HVO-3000MT video recorders, it records images from 3D/2D endoscopic camera systems or surgical microscopes onto its high-capacity internal hard drive. Video can be stored simultaneously on up to two external media devices, including Blu-ray, DVD, USB memory or a hospital server for easy sharing, vital for improved collaboration in hospital environments. It’s also more user-friendly, with a builtin 3,5 inch (8,9 cm) LCD colour display for controlling input sources or reviewing images, and enhanced

functions like two-channel recording to simultaneously capture images from a connected endoscope and an OR camera. The HVO-3300MT follows the launch of Sony´s first 4K surgical recorder, the HVO-4000MT, earlier this year, which works in tandem with Sony´s Content Management System to provide a complete 4K solution for medical professionals.

Wireless printing for streamlined diagnostics Newly released at the show will be the space-saving UP-D898DC thermal printer. Ideal for use with digital ultrasound systems, it delivers high-quality black & white A6 prints in less than two seconds for quick diagnostics, and operates on a DC power source for convenient integration into a medical cart. The UPA-WU10* wireless printing system will also be on display, allowing cable-free connection between compatible Sony medical printers and surgical endoscopes, ultrasound systems and other imaging modalities. Replacing a conventional wired USB connection, it’s ideal for busy clinical environments where modalities are constantly being moved between different OR and treatment rooms. For further information about Sony’s innovations in the medical sector and the full range of products please visit www.pro. sony.eu *As of November 2016, this system can be used in the EU and the European Free Trade Association (EFTA), the United States, Canada, and Japan.

Medical Device ASIA | November-December 2016 | 41


Apollo Sugar all set to take charge on diabetes this

World Diabetes Day

Launches Apollo Sugar, Centre of Excellence for Diabetes and Endocrine care at Apollo Hospitals, Navi Mumbai 14th November, 2016 was World Diabetes Day, recognized worldwide as a day to promote awareness and education of Diabetes. In our country, we have over 100 million Diabetic, pre-diabetic citizens Diabetes is impacting India as it is continues its march towards becoming a silent epidemic. Data indicates half of the uncontrolled Diabetics also develop cardiovascular complications. To address NCDs like Diabetes, Apollo is proud today to bring Apollo Sugar, our centre of excellence for Diabetes and Endocrine care at our new Navi Mumbai hospital to serve you and your family. With 30 years of Apollo’s healthcare innovation forming the cornerstone of our parentage, Apollo Sugar with its network of 51 diabetes clinics, over 100 endocrinologists and diabetologists and multidisciplinary care team of 150 including dieticians, diabetes specialty nurses and educators stands committed to offering our patients worldclass diabetic care. We aim to provide the highest quality of service and create a healthy difference in the life of those with diabetes, through clinically led, lifestyle backed and technologically enabled model of care. Commenting on the Launch, Dr Prathap C Reddy, Founder Chairman, Apollo Hospitals Group said, “Diabetes is sweeping across India and marching towards becoming a silent epidemic. To combat this NCD, as we launch Mumbai’s first Apollo Hospital, we are happy to announce that this facility houses our exclusive centre of excellence for diabetes & endocrine care – Apollo Sugar. I am delighted to share that Apollo Sugar’s proven diabetes & endocrine care delivers excellent clinical results. There has been a significant 16% decrease in HbA1c in patients enrolled with Apollo Sugar’s flagship annual program – Sugar 360. We are proud to bring this centre of excellence to Navi Mumbai and look forward to serve the community with our leading edge programs.” Speaking on the occasion, Mr Gagan Bhalla, Chief Executive Officer, Apollo Sugar said, “Apollo Sugar today launches its 5th clinic in the city of Mumbai, and strengthens our ability to serve Mumbaikars with comprehensive, end-to-end diabetes care through its holistic diabetes and lifestyle management programs. We aim to help Mumbaikars live a disease free diabetes lifestyle, and hand-hold Mumbaikars in managing every aspect of their Diabetes. We are committed to improving the diabetes health of individuals and communities by delivering proven and internationally acclaimed standards of care at affordable price points, thus helping improve patients’ health, and preventing complications.” About Apollo Sugar: Apollo Sugar, Apollo Hospital Group’s flagship chain of innovative single speciality clinics in collaboration with Sanofi, is committed solely to providing world class care for diabetics in India. Apollo Sugar was formally announced on September 30th 2014, by the group. It envisages to be a nationwide movement and one that brings together the government, industry, doctors and consumers in joining hands in the crusade against diabetes. Today, Apollo Sugar has brought in technological advancement by investing in the best-in-class equipment to cater to diagnosing and better managing diabetes and related complications. As an integral part of the Apollo Group that has a thirty years’ legacy of progressing healthcare in India, Apollo Sugar makes unrelenting efforts to transform lives through treatment, empowerment and Tender Loving Care, a hallmark of the Group. 42 | November-December 2016 | Medical Device ASIA

FET launches new FET-100 Series for Biomedical market

Fibre Extrusion Technology Ltd of Leeds, UK has launched an upgraded range of bespoke equipment used in the manufacture of specialist yarns for biomedical applications. This coincides with a £1 million investment in its in-house Process Development Laboratory which allows client trials, proof of concept testing, collaborative research, sampling and prototyping. Established in 1998, Fibre Extrusion Technology Ltd is a leading supplier of laboratory and pilot melt spinning systems with installations in over 30 countries. This equipment is highly suitable for the development and small volume production of exotic and difficult-to-process biomedical materials, such as resorbable polymers used in medical devices. These include the Engineering Polymers such as PPSU, PEI, PEEK and PC. FET systems are also suitable for processing sustainable polymer types (S-Polyamides, PLA, PHA, S-PET etc.) The FET-100 Pilot Series offers considerable flexibility with interchangeable production formats: • FET-100 Extrusion • FET-101 Multifilament • FET-102 Nonwoven • FET103 Monofilament FET-100 systems can be specified to be multi-functional, allowing easy and fast conversion between material formats. It configures to all combinations of multifilament, monofilament and melt spinning of nonwoven structures for medical device applications. Extrusion module options include multi-polymer capability, bi-component, tri-component and can be specified for high temperature capability and corrosion resistant construction. The bi-component systems are ideally suitable for yarn engineering and particularly in sheath core format. This facilitates the inclusion of functional materials into the polymer matrix. Where melt spinning solutions cannot succeed for technical reasons, there is the option of the pilot and small scale production FET-200 wet spinning systems. These may be used for a variety of solvent and polymer combinations used in the biomedical industry.


Increased domestic demand transforms Brazil’s Health Devices Industry

BRAZILIAN COMPANIES PRESENTED INNOVATIVE SOLUTIONS FOR A VARIETY OF AREAS AT MEDICA 2016 The product portfolio for different procedures and treatments is the result of a conscientious innovation strategy and R&D investment

The sector’s growth leads to higher quality and falling prices for Brazilian medical, dental, hospital and laboratory products and equipment

ABIMO (the Brazilian Medical Devices Manufacturers Association) studies have shown that innovation is considered essential by the Brazilian industry in the sector. At least 80% of companies have their own R&D departments and more than 2/3 (68%) have a strategic innovation plan.

The expansion of the middle class in Brazil over the past decade has provoked an increase in the domestic demand for health devices, driving the industry to increase investment into innovation and higher quality. Over the past six years, the sector’s apparent consumption has accumulated real growth of 11.5%. Just for the past year, the real growth in apparent consumption was 4%, despite the slowdown in the country’s economy. “We are living a period of profound transformation, because the growth in demand and changes in the profile of consumption of health devices is driving the sector to mature. We are producing more, with higher quality and lower costs”, explains ABIMO (the Brazilian Medical Devices Manufacturers Association) superintendent Paulo Henrique Fraccaro. Another factor that contributes to the development of the local health devices industry is the modernisation of hospital infrastructure seen over the past few years, which has increased the volume of medical tourism to Brazil. The international recognition of the quality of the country’s plastic surgery and cosmetic medicine has also driven the national health devices industry. Brazil is among the top 10 countries with the highest number of plastic surgeons and certified cosmetic medicine specialists in the world. Procedures such as breast enlargement, for example, are carried out at a lower cost than in countries such as the US or UK. Brazil also stands out as a global destination for treatment in the areas of oncology, cardiology, orthopaedics and neurology.

Excellent cost-benefit The industry’s transformation is reflected in the image Brazilian products have abroad. Research conducted by ABIMO among key opinion leaders and clients in target markets for the sector, such as Angola, Chile, Spain, the US, India, Mexico and Turkey indicated that Brazil’s products are seen as offering excellent cost-benefit with creative and innovative solutions. The study shows that Brazilian dental products and equipment are considered some of the finest in the world. In Russia, for example, Brazil is the market leader in sales volume of dental equipment. Brazil’s export list to the US, Europe and the Middle East includes sophisticated products, such as neonatal incubators, which reach the market based on their quality and competitive prices. In Latin America, Brazilian paediatric heaters and light therapy equipment are of particular note. In general, Brazilian electrosurgical equipment is considered reliable in the medical product markets it is exported to and the same holds true for its ophthalmological and refractive surgery equipment. The Brazilian health products industry were represented at MEDICA 2016, in Dusseldorf, by 50 companies, of which 3 were in the National pavilion, participating off their own resources. The companies are members of the Brazilian Health Devices project run by ABIMO (the Brazilian Medical Devices Manufacturers Association) in partnership with Apex-Brasil (the Brazilian Trade and Investment Promotion Agency).

“In the current global trade scenario of competition and dynamism, investing in innovation is a necessity and Brazil’s health products and equipment industry already knows it, as evidenced by our research”, says Clara Porto, the ABIMO marketing and exports manager. “Recognising this reality, ABIMO created the Health Innovation Prize back in 2010, to honour the most innovative solutions offered by the Brazilian industry”, she adds. Below is some of the innovation Brazilian companies: FOR LUNGS Magnamed creates lung ventilator and anaesthesia solutions, exporting two of its machines – the OxyMag is a portable ventilator, while the FlexiMag Plus is an ICU ventilator – to more than 40 countries. The innovation in the OxyMag is that it has an intuitive, user friendly interface that makes it easier and faster to take action in emergencies. The company won the Innovating Health Prize in 2013. Timpel won the Innovating Health Prize in 2015 for its Timpel Enlight 1800, a bedside lung monitor for use in hospital environments (ICU, Surgery Centre, Accident and Emergency and Walk-in Clinics). The device provides real-time imaging of lung ventilation/perfusion distribution, making it possible to identify collapses and alveolar hyperdistention, filling assynchronisms, pneumothorax, selective intubation and lung perfusion alterations, among others. The equipment carries out ultra-fast image capture (50 per second), issues no radiation and does not require the use of contrasts. It offers the patient more safety, physicians can use it to diagnose the lung condition more quickly, it optimises ventilation (supports the decision) and allows for fast haemodynamic checks (while being non-invasive). VENIPUNCTURE Duan International developed the Venoscópio, a creative and inexpensive solution. This tool uses LED lights that shine onto the skin, permeating the subcutaneous tissue by up to 5 mm, and highlights veins, allowing the health professional to identify the three main parameters for a good venepuncture: real vein calibre/diameter, pathways/branching, and existing permeability/obstructions. The image of the vein is direct, not reflected, which reduces the risk of error. Another advantage the Venoscópio offers is that it allows visualisation of whether the medication is kept to the lumen of the vein and to identify haematomas in accidents, as a perforation of veins. The Venoscópio dispenses the use of garrottes and tourniquets. Furthermore, it improves the blood collection by being faster than the traditional procedure, also reducing the risk of biochemical and haematological alterations in the sample. REHABILITATION Ibramed, a manufacturer of rehabilitation and aesthetic medicine equipment, developed a product especially for the Rio 2016 Olympics – the Neurodyn Aussie Sport. This product accelerates athletes’ recovery process after an injury through the use of the Corrente Aussie to for sensory and motor stimulation. It is mainly indicated for muscular strengthening, motor re-education, reducing oedemas and modulating pain, among others. FOR THE HEART Corcam innovated with the Nexcor, a system that brings current hospital technology to users, getting cardiac patients close to their physicians. The monitor can identify infarction in its initial phase and rare arrhythmia syndromes using software that sends real-time patient data to a centre that passes on the information to the respective physicians. Developed over the course of five years of research, the new heart monitor can detect falls, has a GPS to locate patients who have lost consciousness and a panic button to call for help with one touch, in addition to sending alerts in the event of infarction or arrhythmia. Scitech was the first company in South America to develop a pharmacological stent, an implantable product for the treatment of coronary diseases. The company was also a pioneer in the region, in developing a non-pharmacological coronary stent and accessories for interventionist cardiology. Medical Device ASIA | November-December 2016 | 43


MeriConnect makes surgical video and image handling simpler and more efficient

BM 77 Bluetooth®: Upper arm blood pressure monitor with XXL display Upper arm blood pressure monitors provide reliability you would expect from the doctor’s. The BM 77 Bluetooth® also ensures maximum user comfort with its fully automated blood pressure and pulse measurement on the upper arm, universal cuff, XXL display and transfer of measurements to the “beurer HealthManager” app and PC software. The device is also suitable for measurement during pregnancy.

Easy to operate

Video recordings in the operating room are becoming more common as non-invasive surgery and new medical technology are emerging. Additionally, hospitals need to pay more attention to the quality of care which increases the need for traceability. Merivaara now offers a solution, MeriConnect™, that enables surgeons to access and edit images and videos immediately after surgery at their own desk. This helps to save time, speed up the operating theatre turnover and improve patient safety. MeriConnect is a browser based integration and archiving system, designed to function with Merivaara OpenOR™, a vendor-independent operating room (OR) integration and image handling system. MeriConnect allows users to store, edit and transfer data directly after surgery. It can be used in addition to existing PACS and other archiving systems or even entirely replace them. The system consolidates and stores data from surgical imaging, radiology, hospital information systems and clinical databases with short or long term retention policies. MeriConnect makes data accessible for surgeons and clinicians from their own computers outside the OR without the need for any client software. The documentation tool provides highly visual and easy-to-use features enabling fast and efficient diagnostics and reporting. By connecting with the hospital’s existing systems, MeriConnect allows hospitals to have smooth and functional multi-vendor environments. OpenOR is Merivaara’s revolutionary open architecture management system that integrates operating room devices, data and image management based on the need of the surgical department. Additionally, OpenOR enables real-time remote consultation and flexible telemedicine. Together with MeriConnect OpenOR provides hassle-free and efficient image and video handling that help surgeons concentrate on what they do the best.

13 - 16 November 2017 Düsseldorf, Germany 44 | November-December 2016 | Medical Device ASIA

Blood pressure and pulse measurement is carried out fully automatically on the upper arm using a universal cuff for upper arm circumferences of 24 – 40 cm. The measurement values are displayed on an easy-to-read, illuminated XXL display. The coloured scale helps you to classify the measurements. The measured values can be transferred to the “beurer HealthManager” app or PC software using Bluetooth® or a USB port. There are 2 x 60 memory spaces available. The medical product calculates the average of all stored values and also stores the average morning and evening blood pressure for the last seven days.

Reliable measurement The user is warned by an error message in the event of incorrect usage. The patented resting indicator (patent EP 1 673 009) provides added reliability as it checks whether the blood pressure is taken at rest at the time of measurement. The BM 77 also has arrhythmia detection. The device additionally offers reliable measurement during pregnancy. Beurer FM 150 leg compression therapy – a new lease of life for tired legs After a long day, legs can often feel heavy. The Beurer FM 150 helps recovery by delivering a revitalising pressure massage that relieves muscle tension and promotes blood circulation. The FM 150 leg compression therapy will be presented at MEDICA 2016. That “heavy leg” feeling can be caused by inactivity or one-sided strain. The FM 150 improves vein function and relieves tension by providing a pressure massage. This works as follows: If you have weak or diseased veins, vein valves do not close. As a result, the blood backs up. The pressure of the compression massage restores the vein valve function. The blood flow to the heart is stimulated, thereby relieving muscle tension and preventing varicose and spider veins. The compression massage provided by the FM 150 is delivered via two leg cuffs with integrated inflating and deflating air cushions. The leg cuffs are alternately inflated, helping to reduce swelling and heavy legs. The leg cuffs can be adjusted individually using the hook-and-loop fasteners to ensure a comfortable fit. The massage intensity is continuously adjustable. A safety STOP button interrupts inflation if the pressure is uncomfortable. The deflation function enables the air cushions to be emptied quickly – operated via a hand switch. A timer function is also available for time intervals of 10/20/30 minutes. The product comes with a storage bag for transportation when on the move. The FM 150 is an approved medical product. It can be operated on battery or mains power.


Beurer AS 95: Keeping up with day-to-day life

W

hether normal walking or targeted running training: exercise keeps you healthy. With the AS 95 Pulse activity sensor, Beurer is presenting a product which combines counting steps and pulse measurement at the MEDICA 2016. When linked to a smartphone, the AS 95 Pulse additionally provides notifications for incoming calls and messages. AS 95 Pulse activity sensor The AS 95 features a high-quality design, making it the perfect business partner. After all, not only does it boast the functions of an activity sensor and a heart rate monitor, the AS 95 Pulse also alerts the user to incoming calls, SMS and messages and displays the date, time and battery state. Measured values are automatically saved for 30 days and nights. The OLED XL display is extremely easy to read. Water splashes are also not a problem for this device thanks to its splash-proof design.

1. Activity and sleep tracking Every step counts. That is why the activity sensor records every step and provides information about the number of steps, distance covered,

calorie consumption, activity duration and achievement of the daily activity goal. It records sleep motion activity and sleep duration during the night. The free “Beurer HealthManager” app enables optimum, accurate activity monitoring and sleep analysis.

TRILUX Medical GmbH & Co. KG - The reLED OR light for the best illumination: TRILUX Medical Aurinio Wave® A new dimension in light

2. Pulse measurement The pulse is measured on the wrist via an optical sensor, enabling live tracking of the heart rate via Runtastic or other fitness apps, for instance.

3. Notification function If the Bluetooth® function on the smartphone is enabled, the AS 95 will alert the user to incoming calls and SMS, displaying the number or the name stored in the smartphone. The relevant symbol is displayed for incoming messages via WhatsApp or Facebook.

Health Enterprises’ New DryEars at Medica Health Enterprises, a leading manufacturer of niche health care products, displayed their innovative, new DryEars ear drying device at Medica. The patented DryEars uses air to safely and effectively dry and remove trapped water from ears. The product works in approximately 20 seconds, is safe for children over 3 years of age, and helps to prevent “Swimmer’s Ear”. Health Enterprises, a division of Apothecary Products LLC, is a leading manufacturer of branded and private label OTC consumer healthcare products sold in retailers across the globe. For more information about Health Enterprises and its complete product line, visit www.healthenterprises.com.

Medical technology specialist TRILUX Medical has released a new generation of its highly efficient and ergonomical OR lights during recently held MEDICA. Aurinio Wave® with reLED technology is the only OR light to combine a shadow-free luminous field with unique illumination depth and elevated colour rendering. This new dimension of light enables OR teams to work undisturbed in any situation. Its high performance level as well as simple embedding in existing OR integration systems make Aurinio Wave® the ideal light source for discerning surgeons. A short extract from the concentrated power of Aurinio Wave®: - reLED technology: lighting technology developed by TRILUX Medical - Impressive light column for working in any position - Luminous field with precise focussing for illuminating deep wounds - LAS technology: built-in power reserve for 100 % lighting performance over the entire lifespan - and much more…

Medical Device ASIA | November-December 2016 | 45


Oscare Medical showcased unique handheld ultrasound device for osteoporosis assessment at Medica 2016 Makes screening for osteoporosis simple, reliable and affordable

O

scare Medical Oy demonstrated its handheld low frequency

bone cortical thickness, bone elasticity and bone mineral density (BMD),

ultrasound device, the OsCare Sono® for osteoporosis

including BMD of the deeper cortical layers – suggesting that the device

assessment, at this year’s Medica at the Team Finland booth B5

uniquely offers enhanced sensitivity to early osteoporotic changes.

in Hall 15. Medica, the world’s largest medical exhibition, was held from 14th - 17th November in Düsseldorf, Germany. Osteoporosis is estimated to affect 22 million women and 5.5 million men in Europe, with most of them unaware that they suffer from this silent disease until they suffer one or several low energy fractures. One out of three women and one out of five men 50 years old will experience osteoporotic fractures in their remaining lifetime.

About Oscare Sono® The Oscare Sono® is a compact, handheld device designed for osteoporosis risk assessment in clinics and low-threshold locations, such as high street pharmacies. The device attaches via a USB connector to a standard PC. A measurement is taken from the forearm over a few minutes using harmless ultrasound. An individual’s measurement is compared to

The dual energy X-ray method (DXA) is the gold-standard for confirming

the normal value observed in healthy young women, and the final Oscare

a diagnosis of osteoporosis, but the expense, and limited availability, of

Sono® result is ready for counseling.

DXA make it an impractical technique for screening people at an increased risk for osteoporosis. By assessing bone strength from the forearm radial

About Oscare Medical

bone using ultrasound, the OsCare Sono® allows for safe and inexpensive assessment of an individual’s osteoporosis risk. Because OsCare Sono®

Oscare Medical was founded in 2007 to commercialize the results of a

is easy to use and provides the measurement result in a matter of

decade of research into bone health at the University of Jyväskylä, Finland.

minutes, it is especially suitable for screening. Those individuals found to

Since 2013, Oscare Medical has been majority-owned by Nasdaq-OMX-

be at an increased risk for osteoporosis based on the OsCare Sono® measurement result, can be directed for further investigation with DXA, according to doctor’s judgement. OsCare Sono® measurements have been shown to correlate with 46 | November-December 2016 | Medical Device ASIA

listed Revenio Group Corp which also markets the hugely successful Icare® tonometer product family. The Oscare Sono® is CE-marked and is on sale in several European and Middle Eastern countries. Oscare Medical is rapidly expanding its distribution partner network. For more details, please visit: www.oscaremedical.com


EIZO Expands Connectivity in the Operating Room with New Functionality for Video Management Systems and OR Monitors daisy-chained equipment via the loop-through output. With its introduction in 2008, EIZO’s LMM revolutionized video management in interventional radiology rooms. This has since expanded to offer fast, flexible and convenient control of video sources in control rooms, OR and other applications with multiple video inputs. The new TID0102 splitter expands the connectivity options for the LMM and other point-to-multipoint video systems.

E

IZO GmbH announced the expansion of their CuratOR operating room (OR) solutions portfolio. With the release of the EX271W OR monitor and its two new video input modules, the TID0102 splitter, and the CID1201P application for the Large Monitor Manager (LMM) video management system, EIZO offers even more flexibility in connecting and operating system components. Designed to complement EIZO’s Transmission Data Link (TDL) portfolio, the new High-Definition Link (HDL) transmission technology makes use of standard CAT6 cables to transmit uncompressed video up to distances of 70 meters. This reduces the cost of system planning and installation, particularly when deployed in conjunction with EIZO’s new EX271W, a 27-inch monitor for the OR with an innovative modular design. From its inception, the EX271W was designed as a modular monitor to support targeted connectivity in the OR. With its slim design, low weight and high IP rating, the EX271W is an ideal video front-end for the LMM or other OR equipment offering state-of-the-art medical imaging at 1080p. To further expand the EX271W connectivity options, EIZO is introducing the TRM0000-HDL and TRM0000-3GS OR monitor modules. The TRM0000-HDL module allows the monitor to interface directly with the TID0102-HDL or other HDL-compatible transmitters. In this way, video information can be sent from a centralized equipment room into the OR. Similarly, the TRM0000-3GS module lets the EX271W monitor receive 3G-SDI video signals in surgical environments and to forward the signals to

With the established DVI video interface of the TID0102-DVI, system designers can use a wider range of video components along with EIZO’s growing portfolio of professional, high-resolution medical monitors. In addition to supporting control room solutions, the TID0102-HDL model splits each video output into two distinct pathways, allowing replication of the signals on two separate monitors with no additional latency or degradation of the video signal. The secondary output is ideal for use with a TRM0000-HDL module

or other HDL-compatible receiver. When used in a stand-alone configuration, the TID0102-HDL can display the DVI input signal from a video management system on up to four monitors. As the successor to EIZO’s CID1000P, the new CID1201P application offers a userfriendly interface for the LMM. With the higher resolution and improved touch responsiveness of modern panel PCs, the CID1201P application enables quick and intuitive selection of video sources through the LMM’s view management interface. The software was designed to be robust and secure in the OR environment, and setup is as simple as specifying the LMM video management system address.

Availability The new products will be released in series at the end of 2016. Date of availability varies by country so contact the EIZO group company or distributor in your country for details.

About EIZO GmbH EIZO GmbH is based in Karlsruhe, Germany and is a leading manufacturer of visual display solutions for medical imaging applications. The company portfolio includes color and grayscale monitors of 1 to 8 megapixels, video management systems and related accessory products. EIZO GmbH is a subsidiary of EIZO Corporation, a global leader in the manufacture of high end monitors for medical and graphic design applications, financial trading, and other markets. For more information, please contact: EIZO GmbH Tel: +49 721 20321-0 www.eizo-or.com dt-contact@eizo.com Medical Device ASIA | November-December 2016 | 47


EIZO Expands Portfolio of CuratOR Surgical Panels with Additional Monitor Sizes, 8 Megapixel, and Touchscreen Options monitor used as a workstation for image viewing and documentation. There is a wide range of freely configurable variants in addition to what is offered with the standard models. This means that the number and size of the monitors, the material and color, integrated accessories, interfaces, as well as PC and IT components can be selected and integrated according to customer wishes or the requirements of the operating room. In addition, EIZO’s software for OR integration, CuratOR Caliop, can best be operated using the Surgical Panels.

About EIZO GmbH

EIZO GmbH announces new standard models within its portfolio of CuratOR Surgical Panels. The existing selection of models is now expanded to include additional monitor sizes, touchscreen models, and a large screen with up to 8 megapixel resolution. EIZO has responded to the numerous customer requests for preconfigured models in the CuratOR Surgical Panel range. The Surgical Panels from EIZO are based on the proven EIZO product range and enable inspection, operation, and video management from a central workstation in the operating room (OR). The following standard models are available with new monitor sizes: SP1-42: This Surgical Panel with a built-in 42-inch monitor is an intermediate size between the standard 24-inch and 46-inch monitors that are already available. It is used as a workstation for OR nursing staff or for image viewing. SP1-55: This Surgical Panel with a 55-inch monitor is used as a large-scale workstation for image viewing and is available with FHD (Full HD) or 8 megapixel resolution (SP1-554K). SP2-24: This Surgical Panel with two 24-inch monitors offers a space48 | November-December 2016 | Medical Device ASIA

saving workstation for image viewing and documentation. The existing Surgical Panels now also offer a touchscreen option. These models come with a glass capacitive touchscreen which can be easily cleaned and operated while wearing gloves in the OR: SP1-24T: A Surgical Panel with a built-in 24-inch touchscreen monitor used as a workstation for OR nursing staff. SP1-46T: A Surgical Panel with a built-in 46-inch touchscreen monitor used as a workstation for image viewing. SP2-24T-49: A Surgical Panel with a built-in 24-inch touchscreen monitor and built-in 49-inch

EIZO GmbH is based in Karlsruhe, Germany and is a leading manufacturer of visual display solutions for medical imaging applications. The branch office of EIZO GmbH in Plauen, Germany is solely dedicated to the development, production, and sales of OR solutions. The company’s portfolio includes color and gray-scale monitors from 1 to 8 megapixels, image management systems, and accessories as well as individual products and complete solutions for the OR. EIZO GmbH is a subsidiary of EIZO Corporation, a global leader in the manufacture of high-end visual display solutions for medical and graphic applications, air traffic control, and other markets. For more information, please contact: EIZO GmbH Plauen branch office Tel: +49 3741 42365-0 www.eizo-or.com info@eizo-or.com


The world’s first integrated BIA and vital signs measurement from seca is pushing the decline of the Body Mass Index

Innovative seca technology raises diagnostic potential to a higher level Malnutrition, obesity, Type 2 diabetes and all their consequences are among the world’s major medical challenges of the 21st century. Nevertheless, the assessment of a patient’s state of health and nutritional status is still based on classic vital signs and BMI (Body Mass Index). As critical parameters of body composition are not measured, the opportunities to initiate preventive measures or to optimize treatment remain unused. The seca medical Vital Signs Analyzer (mVSA) compensates for the weaknesses of BMI and increases the potential of non-invasive, ad hoc diagnostics to a completely new level.

Bioimpedance and vital signs analysis – A dynamic duo for optimized diagnostics The seca mVSA is the world’s first Spot-Check Monitor which measures the four classic vital signs of blood pressure, SpO2, pulse and temperature plus body composition consisting of fat mass, muscle mass and body water by means of Bioimpedance Analysis (BIA). seca had the precision of these BIA parameters validated against respective gold standards in a multi-center study[1] involving different ethnic groups. The options of combining data from body composition and vital signs yield a much faster and more differentiated assessment of the patient’s state of health and nutrition status than is possible with vital signs and BMI alone. At the end of the very brief examination, the doctor immediately has all the information required for decision-making.

Cross-indication gains for diagnostics and treatment The seca mVSA has added value beyond the treatment of obesity, malnutrition and diabetes. Cross-indication patients and users benefit from the findings, simple operation and especially from the combination options of measured data as the following examples show:

improvement of the general health status and an associated rise of the phase angle can be achieved through movement (aerobic exercise). Physical training can improve body composition and the patient’s well-being. Monitoring the phase angle and regular SpO2 measurements using the seca mVSA should accompany these therapies.

Fluid Management – Timely restoration of hydration status Controlled rehydration treatment for patients suffering from exsiccosis reduces the load on the heart. With blood pressure and BIA measurements and regular monitoring of the BIVA chart (Bioelectrical Impedance Vector Analysis (BIVA), which provides graphic representation of the patient’s fluid level and cellular mass), medical staff can see whether a healthy hydration level has been achieved. The simultaneous, non-invasive BIA and blood pressure measurement with the seca mVSA saves time and offers a reliable ad hoc assessment of the patient.

Heart Failure – Optimized management of diuretics with dual measurement Edemas due to heart failure are easier to detect through the results of the seca mVSA. The regular measurement of body composition and blood pressure during diuretic therapy provides valuable information on the health status of the patient. The administration of diuretics can be better controlled through the dual measurement of blood pressure and extracellular water.

Chronic Obstructive Pulmonary Disease (COPD) In addition to the general check of oxygen saturation via pulse oximetry (SpO2), it is also sensible in this case to examine the general body composition (e.g. phase angle) to evaluate the entire situation. An 50 | November-December 2016 | Medical Device ASIA

Direct data integration in EMR increases efficiency and safety in hospital and medical office routines The monitoring of vital signs is one of the most time-consuming activities in hospitals and medical practices. The seca mVSA was developed to support these routine checks and lighten the workload. All vital parameters and BIA data are captured quickly by one device and stored directly in the digital patient files. As a part of the seca 360° wireless product world, the seca mVSA provides automatic transmission of height

and weight from compatible scales and measuring systems to the device. The benefits are clear: efficiency improvements, timesaving procedures and paperless and error-free transmission of measurements. Please find more information about seca, seca products and seca service at www.seca.com and www.secashop.com.


MEDICAL FAIR ASIA 2016 continues to grow, in size and importance, reporting record-breaking numbers for its 11th edition The region’s leading exhibition for the medical and healthcare sector, MEDICAL FAIR ASIA, was a major success earlier this month packing its new and larger venue, the Sands Expo and Convention Centre, with the highest ever number of satisfied exhibitors and visitors.

M

EDICAL FAIR ASIA 2016, 30% larger than the previous edition in 2014, was entirely filled to host the 830 international companies from 40 countries. The exhibition featured international brand names such as Perry Baromedical, Swann-Morton, and Hitachi, and 17 national pavilions and country groups. Local companies like RAS Pharma and Yeap Medical Supplies were strongly represented too at MEDICAL

FAIR ASIA 2016.

Visitor numbers also increased this year to a record-breaking attendance of 12,000, with 40% of visitors from abroad. The overseas visitors came from all over Southeast Asia along with India, Japan, South Korea, China, Hong Kong, Taiwan and Australia. Over the three action-packed days, the organiser also facilitated a personal best of 1,100 pre-scheduled meetings via the synergistic business matching service with many formal business dealings coming to fruition during the exhibition. “The event has been extremely interesting and we have had some incredible meetings. The business matching service has been able to match us up with various organisations to have some discovery meetings about ways we can work together. At the same time, it has exposed us to a lot of the technology in Southeast Asia that we would not have been aware of otherwise,” noted Darryl Culley, President of Emergency Management Inc. Gabe Mensinga, Senior Project Manager of Leader Biomedical said, “Our expectations were already surpassed on the first day of the exhibition as we had a lot of new leads coming in. There were many people at the exhibition who were interested in our products and we are pleasantly 52 | November-December 2016 | Medical Device ASIA

surprised as to how good it has been!” Honed as an international marketplace in the healthcare and medical sector, MEDICAL FAIR ASIA 2016 was joined by returning national pavilions and country groups from North America, Europe and Asia, whilst also welcoming two new first-time national pavilion participants — Turkey and Saudi Arabia. “Southeast Asia is an emerging market and one that everyone should target, which is why we have decided to participate at MEDICAL FAIR ASIA. We have come here with high expectations and our experience has been entirely positive. This exhibition has been a gateway for our companies to enter these markets,” said Nasser M. Alrashed of Saudi Export Development Authority. Recent editions of MEDICAL FAIR ASIA have seen growing exhibitor

interest from North America and the Middle East, due to the attractive burgeoning growth in Southeast Asia. The co-location of MEDICAL FAIR ASIA with MEDICAL MANUFACTURING ASIA, the region’s leading event for the manufacturing processes for the medtech sector, is another big draw as between them the two exhibitions provided the ideal platform for all those involved in medical and healthcare; a point which was highlighted in the opening speech by Mr S Iswaran, Minister for Trade and Industry. He stressed Singapore’s strong position as a gateway for medtech companies, both local and foreign, to access growing markets in the region, and Singapore’s reputation as a trusted business hub. Trade visitors also praised MEDICAL FAIR ASIA 2016 as an excellent event with global relevance, which was excellent for business


development and knowledge enhancement within the region. Manager of RS Awal Bros, Batam Hospital, Dr Retno Kusumo has attended every edition since 2010 to see the latest products and to keep up with new technologies. She said, “The show has grown significantly over the last couple of years. This year we were especially looking forward to the new Saudi Arabia and Turkey pavilions. We typically attend MEDICAL FAIR ASIA to procure medical consumables and devices and gain new perspectives and information, which we acquired.” Mr Tuan Le Thanh, Director of Y Duc Medical Equipment said, “This was the fourth time that I have visited MEDICAL FAIR ASIA to look for new products to promote in the Vietnamese market, particularly technologies and solutions in the area of telemedical diagnostics. In addition to the show floor, I also looked forward to attend some of the concurrent seminars.” Making their debut alongside the exhibition were a series of wellattended expert conferences and seminars, technical presentations and product demonstrations that represented a significant milestone for MEDICAL FAIR ASIA which has a well-established history of over two decades. The inaugural staging of the MEDICAL FAIR ASIA MEDICINE + SPORTS CONFERENCE, Disaster and Military Medicine (DiMiMED) Asia Conference and the Medical Innovation and Technology Forum, saw 300 attendees from 24 countries take part in 11 sessions. Delegates were able to assess recent developments in

the respective disciplines – from preventive and rehabilitative medicine, latest generation sports equipment, to vector-borne diseases and issues of natural disasters, as well as healthcare wearables and telemedicine solutions – to exchange ideas and bring their knowledge up-to-date. Dr Ben Tan, Chief of Sports Medicine, Changi General Hospital, said of the conference, “I hope to see the MEDICINE + SPORTS CONFERENCE back. MEDICAL FAIR ASIA is the biggest medical trade fair I have seen in Singapore with an impressive number of exhibitors. Linking the exhibition with a medicine and sports conference is logical and synergistic. Moreover, it has been very professionally organised.” Mr Gernot Ringling, Managing Director of Messe Düsseldorf Asia, organiser of MEDICAL FAIR ASIA, expressed his delight at the impressive participation results “We are very happy with the results and feedback from the 11th edition of MEDICAL FAIR ASIA and the wellattended series of conferences and concurrent events. Many of our stakeholders have reported doing real business at MEDICAL FAIR ASIA 2016 which bodes well for developing business opportunities.”

About MEDICAL FAIR ASIA 2016 Organised by Messe Düsseldorf Group, the world’s leading organiser of medical trade fairs, MEDICAL FAIR ASIA is part of the ”World of MEDICA” brand and has established itself as the region’s leading international exhibition on hospital, diagnostic, pharmaceutical, medical & rehabilitation equipment & supplies. Following its successful growth path since its inception in 1997, MEDICAL FAIR ASIA acts as the gateway to Asia for global industry players by providing the perfect platform to showcase the latest industry innovations, to network and do business. For more information, please visit www.medicalfair-asia.com

The next edition of MEDICAL FAIR ASIA will be held in 2018. Up next for the medical and healthcare industry will be the 8th edition of MEDICAL FAIR THAILAND, to be held in Bangkok from the 6 – 8 September 2017. Participation details are now available at www.medicalfairthailand.com Medical Device ASIA | November-December 2016 | 53


Time To Gearup For:

3D printing: customized insoles for diabetes patients In the past, insoles for patients with diabetes were hand-made by orthopedic shoemakers. In the future, these specialist shoemakers will be able to produce insoles more cost-effectively thanks to new software and the use of 3D printers. This approach means the mechanical properties of each insole can be assessed scientifically and more effectively.

INDIA MEDICAL SHOW is an International Event on Innovation, Technology, Products, Equipment, and Hospital Supplies for the Healthcare Sector in India. It will be held from 17-19 February 2017 at Auto Cluster Venue, Pune- Maharashtra, India. The show will be launched as a part of a series event premiering at Pune in Maharashtra followed by other cities. Participating at INDIA MEDICAL SHOW will be an excellent opportunity to meet, interact and showcase your latest range of products Doctors – Physicians & Surgeons, Hospitals owners & Decision Makers ,Dealers Distributors & Manufacturers of Medical Equipments, Owners of Diagnostic & other Healthcare Centers,Medical Directors,Academicians,Key policy makers from the governmental sectors, Purchase Managers, Biomedical Engineers, Healthcare Professionals and paramedical staff, Healthcare Consultants etc. across the state and country. There is no tool in marketing more effective for winning new business than participating in a trade fair event by finding innovative ideas and networking!

What you can expect: • The Launch of latest products, technologies and solutions by the market leaders from home & abroad. • Good opportunity for Establishing partners for cooperation, such as joint-venture, projects or distribution network. Parallel to the event there will be a high level conference which is being organised by VOH. Voice of Healthcare (VOH) is a non-profit organization and a platform for all the responsible individuals, professionals and institutions of healthcare to raise their voices in the welfare of healthcare For further queries please feel free to get back to us and we shall be happy to assist. For more information, please contact: Ms. Swati Sharma +91 7038978212 info@indiamedicalshow.com sales.ulexpo@gmail.com 54 | November-December 2016 | Medical Device ASIA

3D structures made of TPU for insoles. These structures were designed using CAD, and their properties were simulated and compared with experiments; © Fraunhofer IWM

Is your shoe too tight? Normally you would just shift your weight to take the pressure off the area that is sore. In people with diabetes, however, the nerve endings in the foot often become atrophied, and those affected cannot feel the soreness. This can give rise to pressure points and eventually wounds that heal badly. A remedy, or at least some relief, is promised by insoles that are very soft in the area of the injury, and that are custom-made by orthopedic shoemakers in a variety of materials. Up until now, however, it has not really been possible to assess the success of insoles scientifically – each insole is a one-off item, after all. So it is in the interests of health insurances companies to have the process surrounding insoles digitalized to allow the collection of scientific data on them. It will soon be possible to digitalize the manufacture of insoles. LAUF, a German acronym for “laser-assisted construction of customized footwear”, refers to a project funded by Germany’s Federal Ministry of Education and Research. Researchers from the Fraunhofer Institutes for Mechanics of Materials IWM and for Environmental, Safety, and Energy Technology UMSICHT are collaborating with industry partners on the process of digitalization. “Digital foot mapping is already common practice. As part of this project, we have now also completely digitalized the insole production process,” says IWM scientist Dr. Tobias Ziegler. “Using newly developed software, the orthopedic shoemaker can design an insole for an individual patient and can print out the result on a 3D printer.” This has a number of immediate advantages: On the one hand, the mechanical properties of each insole become readily apparent, which is something health insurance companies want. On the other, insoles can be produced at greatly reduced cost. In two or so years, this software might be available to orthopedic technicians through IETEC, a member of the project.


Source for the latest high-end manufacturing products / solutions from 400 global solution providers Network with 12,500 trade professionals Keep updated with emerging technologies such as additive manufacturing (3D Printing) and robotics solutions Explore new possibilities at the Capabilities Hub, Optics & Photonics Innovation Hub and Semiconductor Innovation Centre Gain knowledge on IoT in aerospace, inventory & supply chain development in MRO and success stories from aerospace manufacturing at SG Aerospace Connect Discover more about Industry 4.0, automation & additive manufacturing at the Smart Manufacturing Asia conference

Pre-register your visit now at www.mta-asia.com Held Alongside

Incorporating

Organised by

Worldwide Associate Tel : +65 6233 6638 Fax : +65 6233 6633 Email : mta@sesallworld.com

MTA17VPAdMDA_W210xH280mm_D1.indd 1

Endorsed

Supported by

Held in

Tel : +44 207 840 2134 Fax : +44 207 840 2119 Email : mta@oesallworld.com

16/11/16 9:54 AM


Government of India, Registrar of Newspapers of India (RNI)#: DELENG/2009/30008

Profile for Worldwide Publications

Medical Device Asia November-December 2016  

Medical Device ASIA is a bimonthly business magazine on medical device industry. It is the key media partner to major trade shows of the in...

Medical Device Asia November-December 2016  

Medical Device ASIA is a bimonthly business magazine on medical device industry. It is the key media partner to major trade shows of the in...

Advertisement